[Upstream sync] inoue0426/awesome-computational-biology (github) — 6 added, 10 modified #97
upstream/inoue0426-awesome-computational-biology/catalogue/.github/workflows/ai4bio-schema-check.yml
Vendored
+4
-3
@@ -2,9 +2,9 @@
|
||||
title: "Ai4Bio Schema Check"
|
||||
task: ""
|
||||
lineage_type: import
|
||||
upstream_source: https://github.com/inoue0426/awesome-computational-biology/blob/7a064bf0/.github/workflows/ai4bio-schema-check.yml
|
||||
upstream_sha: 7a064bf0
|
||||
imported_at: 2026-08-08
|
||||
upstream_source: https://github.com/inoue0426/awesome-computational-biology/blob/4ed7cfef/.github/workflows/ai4bio-schema-check.yml
|
||||
upstream_sha: 4ed7cfef
|
||||
imported_at: 2026-10-26
|
||||
prompt_class: unknown
|
||||
upstream_changes: accepted
|
||||
author: upstream
|
||||
@@ -50,6 +50,7 @@ jobs:
|
||||
- name: Build enriched artifacts
|
||||
run: uv run --with pyyaml python scripts/build_resources_v2.py
|
||||
- name: Verify enriched artifacts are committed
|
||||
if: github.event_name == 'pull_request'
|
||||
run: |
|
||||
if git diff --quiet; then
|
||||
echo "AI4Bio artifacts are in sync."
|
||||
|
||||
@@ -2,9 +2,9 @@
|
||||
title: "Awesome Computational Biology [](https://awesome.re)"
|
||||
task: ""
|
||||
lineage_type: import
|
||||
upstream_source: https://github.com/inoue0426/awesome-computational-biology/blob/c6f07d90/README.md
|
||||
upstream_sha: c6f07d90
|
||||
imported_at: 2026-08-31
|
||||
upstream_source: https://github.com/inoue0426/awesome-computational-biology/blob/4ed7cfef/README.md
|
||||
upstream_sha: 4ed7cfef
|
||||
imported_at: 2026-10-26
|
||||
prompt_class: catalogue
|
||||
upstream_changes: accepted
|
||||
author: upstream
|
||||
@@ -32,6 +32,22 @@ A curated collection of databases, software, and papers related to computational
|
||||
|
||||
Browse and search the resources via the [GitHub Pages UI](https://inoue0426.github.io/awesome-computational-biology/).
|
||||
|
||||
For treatment-response work, the [Dataset Explorer](https://inoue0426.github.io/awesome-computational-biology/dataset-explorer.html) compares curated cell-line, patient, and PDX datasets by year, sample type, perturbation metadata, matched pre/post availability, SMILES coverage, and clinical outcomes.
|
||||
|
||||
The [Method Explorer](https://inoue0426.github.io/awesome-computational-biology/method-explorer.html) compares drug-response and perturbation methods by task, molecular/context representation, unseen-drug support, dose/time conditioning, and patient transfer.
|
||||
|
||||
The [Foundation Model Explorer](https://inoue0426.github.io/awesome-computational-biology/foundation-explorer.html) compares foundation models by fine-grained modality, parameter count, pretraining scale, species, zero-shot support, weights/code availability, perturbation support, and spatial support.
|
||||
|
||||
The [Agent Explorer](https://inoue0426.github.io/awesome-computational-biology/agent-explorer.html) compares agentic AI systems by scientific domain, single- vs multi-agent architecture, tool/code execution, literature and web retrieval, omics and wet-lab support, autonomy, and human-in-the-loop design. The Agent Explorer table is sortable and supports domain, architecture, omics, code-execution, and year filters.
|
||||
|
||||
All explorer tables support sortable columns and focused filters for quick comparison, including a Recent (≥2025) toggle.
|
||||
|
||||
The Pages home screen also summarizes total resources, profiled datasets, methods, foundation models, agents, and the most common foundation-model modalities.
|
||||
|
||||
Chemical and genetic perturbation datasets can be filtered separately in the Dataset Explorer. Genetic screens can also be filtered by CRISPRi, CRISPRa, knockout, enhancer-targeting, combinatorial, or mixed perturbation modes, including mixed-resource collections.
|
||||
|
||||
The explorer also includes the eight perturbation datasets used in the Bison unseen-compound benchmark.
|
||||
|
||||
- Search matches `name`, `description`, `tasks`, `modalities`, and `tags`.
|
||||
- The **Task**, **Modality**, and **Type** filters map directly to `tasks`, `modalities`, and `type` in `docs/data/resources.json`.
|
||||
- Clicking badges on cards applies the corresponding filter.
|
||||
@@ -236,44 +252,82 @@ Browse and search the resources via the [GitHub Pages UI](https://inoue0426.gith
|
||||
|
||||
## Benchmarks & Datasets
|
||||
|
||||
- [1000 Genomes Project](https://www.internationalgenome.org/) — Reference panel of human genetic variation from 2,504 individuals across 26 populations.
|
||||
- [BACE](https://www.kaggle.com/datasets/gokturkkoch/bace) — Binary classification and regression dataset for β-secretase 1 (BACE-1) inhibitor binding affinity.
|
||||
### Drug Response & Perturbation
|
||||
|
||||
- [BEAT AML](https://biodev.github.io/BeatAML2/) — Functional ex vivo drug sensitivity measurements paired with genomics for acute myeloid leukemia.
|
||||
- [Cancer Therapeutics Response Portal (CTRP)](https://portals.broadinstitute.org/ctrp/) — Drug sensitivity profiles across ~900 cancer cell lines for >400 compounds.
|
||||
- [Chem-PerturBridge](https://github.com/theislab/Chem-PerturBridge) — Harmonized compendium and processing pipelines for small-molecule perturbation transcriptomics across heterogeneous assays and gene panels.
|
||||
- [GSE191127 Breast Cancer Pre/Post Chemotherapy](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE191127) — Bulk RNA-seq and genomics from matched pre- and post-neoadjuvant chemotherapy breast tumors with treatment outcomes.
|
||||
- [Genomics of Drug Sensitivity in Cancer (GDSC)](https://www.cancerrxgene.org/) — Drug sensitivity for ~1000 human cancer cell lines and hundreds of compounds.
|
||||
- [JUMP Cell Painting Datasets](https://github.com/jump-cellpainting/datasets) — Consortium-scale cell imaging perturbation datasets (chemical and genetic) for phenotypic profiling and drug discovery research.
|
||||
- [LINCS L1000](https://lincsproject.org/LINCS/tools/workflows/find-the-best-place-to-obtain-the-lincs-l1000-data) — Gene expression profiles (978 landmark genes) for >20,000 chemical and genetic perturbations across cell lines.
|
||||
- [LINCS L1000 Phase 1](https://github.com/theislab/Chem-PerturBridge) — Phase-1 L1000 benchmark view used by Bison with 692,787 profiles, 9,233 molecules, 70 contexts, and 978 landmark genes.
|
||||
- [LINCS L1000 Phase 2](https://github.com/theislab/Chem-PerturBridge) — Phase-2 L1000 benchmark view used by Bison with 333,263 profiles, 1,760 molecules, 30 contexts, and 978 landmark genes.
|
||||
- [MIX-Seq](https://www.nature.com/articles/s41467-020-17440-w) — Multiplexed single-cell transcriptional profiling of chemical and genetic perturbation responses across pools of cancer cell lines.
|
||||
- [NCI60](https://dtp.cancer.gov/discovery_development/nci-60/) — Drug sensitivity benchmark across 60 diverse human cancer cell lines.
|
||||
- [Novartis Perturbation Dataset](https://github.com/theislab/Chem-PerturBridge) — Large chemical perturbation transcriptomic screen used in Chem-PerturBridge; the Bison benchmark view contains 46,748 profiles and 3,770 molecules.
|
||||
- [OP3](https://github.com/theislab/Chem-PerturBridge) — Chemical perturbation dataset used by Chem-PerturBridge and the Bison unseen-compound benchmark; the Bison benchmark view contains 1,813 profiles, 138 molecules, and 4 cellular contexts.
|
||||
- [PDX-Atlas](https://muralportal.pdxatlas.org/) — Portal integrating clinical, genomic, transcriptomic, and drug-response data from patient-derived xenograft models.
|
||||
- [PharmGKB](https://www.pharmgkb.org/) — Curated pharmacogenomics dataset linking genetic variants to drug response phenotypes across thousands of drugs.
|
||||
- [PRISM](https://depmap.org/portal/prism/) — Cancer drug sensitivity profiling of >4,500 drugs across >900 cancer cell lines using pooled-cell-line barcoding.
|
||||
- [sci-Plex](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE139944) — Single-cell chemical perturbation screen of ~650,000 transcriptomes across three cancer cell lines, 188 compounds, and four doses.
|
||||
- [scPerturb](https://github.com/sanderlab/scPerturb) — Curated and continuously updated single-cell perturbation data resource spanning CRISPR and drug perturbation studies.
|
||||
- [Tahoe-100M](https://huggingface.co/datasets/tahoebio/Tahoe-100M) — Giga-scale single-cell perturbation atlas with >100 million profiles from 50 cancer cell lines exposed to ~1,100 small molecules.
|
||||
- [VCPI-0001](https://github.com/theislab/Chem-PerturBridge) — Bulk chemical perturbation dataset used in Chem-PerturBridge; the Bison benchmark view contains 27,517 profiles and 2,272 molecules in one cellular context.
|
||||
- [VCPI-0002](https://github.com/theislab/Chem-PerturBridge) — Bulk chemical perturbation dataset used in Chem-PerturBridge; the Bison benchmark view contains 18,139 profiles and 1,488 molecules in one cellular context.
|
||||
|
||||
### Genetic Perturbation & Perturb-seq
|
||||
|
||||
- [Dixit et al. 2016 Perturb-seq](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE90063) — Pooled CRISPR knockout with single-cell RNA-seq across K562 and dendritic-cell screens, including stimulated conditions and combinatorial perturbations.
|
||||
- [Adamson et al. 2016 Perturb-seq](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE90546) — CRISPRi Perturb-seq in K562 cells for systematic dissection of the unfolded protein response.
|
||||
- [Datlinger et al. 2017 CROP-seq](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92872) — Pooled CRISPR knockout screen with single-cell transcriptomic readout in Jurkat cells under T-cell receptor stimulation.
|
||||
- [Norman et al. 2019 CRISPRa Perturb-seq](https://figshare.com/articles/dataset/Norman_et_al_2019_Perturb-seq/27766323) — Large-scale CRISPR activation Perturb-seq in K562 cells spanning single-gene and combinatorial perturbations.
|
||||
- [Gasperini et al. 2019 CRISPRi enhancer screen](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE120861) — High-MOI single-cell CRISPRi screen in K562 cells targeting thousands of candidate enhancers to map enhancer-gene regulation.
|
||||
- [Replogle et al. 2022 K562 Genome-wide Perturb-seq](https://plus.figshare.com/articles/dataset/_Mapping_information-rich_genotype-phenotype_landscapes_with_genome-scale_Perturb-seq_Replogle_et_al_2022_processed_Perturb-seq_datasets/20029387) — Genome-scale CRISPRi Perturb-seq targeting nearly all expressed genes in K562 cells.
|
||||
- [Replogle et al. 2022 K562 Essential Perturb-seq](https://plus.figshare.com/articles/dataset/_Mapping_information-rich_genotype-phenotype_landscapes_with_genome-scale_Perturb-seq_Replogle_et_al_2022_processed_Perturb-seq_datasets/20029387) — CRISPRi Perturb-seq focused on essential genes in K562 cells.
|
||||
- [Replogle et al. 2022 RPE1 Essential Perturb-seq](https://plus.figshare.com/articles/dataset/_Mapping_information-rich_genotype-phenotype_landscapes_with_genome-scale_Perturb-seq_Replogle_et_al_2022_processed_Perturb-seq_datasets/20029387) — CRISPRi Perturb-seq focused on essential genes in RPE1 cells.
|
||||
- [Frangieh et al. 2021 Perturb-CITE-seq](https://singlecell.broadinstitute.org/single_cell/study/SCP1064/multi-modal-pooled-perturb-cite-seq-screens-in-patient-models-define-novel-mechanisms-of-cancer-immune-evasion) — Multimodal CRISPR knockout screen with RNA and surface-protein readouts in patient-derived melanoma models under immune-related conditions.
|
||||
|
||||
### Single-Cell & Spatial
|
||||
|
||||
- [HEST Xenium virtual spatial transcriptomics](https://huggingface.co/datasets/ratschlab/HEST_Xenium_virtual_spatial_transcriptomics) — DeepSpot-M predicted transcriptome-wide ST for 59 HEST-1k 10x Xenium samples (~13.3M cells) (gated). Paper: [DeepSpot-M](https://www.medrxiv.org/content/10.64898/2026.06.19.26356060v1).
|
||||
- [scIB (Single-cell Integration Benchmarks)](https://github.com/theislab/scib) — Comprehensive benchmarking framework for single-cell data integration methods.
|
||||
- [Tabula Muris](https://tabula-muris.ds.czbiohub.org/) — Comprehensive single-cell atlas of 20 mouse organs and tissues, enabling cross-tissue and cross-species comparisons.
|
||||
- [Tabula Sapiens](https://tabula-sapiens-portal.ds.czbiohub.org/) — Comprehensive human single-cell atlas of ~500K cells from 24 organs and tissues across multiple donors.
|
||||
- [TCGA virtual spatial transcriptomics atlas](https://huggingface.co/datasets/ratschlab/TCGA_virtual_spatial_transcriptomics_atlas) — DeepSpot-M predicted transcriptome-wide ST for TCGA H&E (FF + FFPE; 28,664 slides / 32 cancer types; gated). Paper: [DeepSpot-M](https://www.medrxiv.org/content/10.64898/2026.06.19.26356060v1).
|
||||
|
||||
### Molecular, Protein & Drug Discovery
|
||||
|
||||
- [BACE](https://www.kaggle.com/datasets/gokturkkoch/bace) — Binary classification and regression dataset for β-secretase 1 (BACE-1) inhibitor binding affinity.
|
||||
- [Bento](https://github.com/LigandPro/Bento) — Protein-ligand docking benchmark covering rigid, flexible, de novo, blind, induced-fit, and covalent docking tasks.
|
||||
- [BindingDB Curated Sets](https://www.bindingdb.org/rwd/bind/chemsearch/marvin/SDFdownload.jsp?all_download=yes) — Curated binding affinity datasets for protein–ligand interaction benchmarking.
|
||||
- [Cancer Therapeutics Response Portal (CTRP)](https://portals.broadinstitute.org/ctrp/) — Drug sensitivity profiles across ~900 cancer cell lines for >400 compounds.
|
||||
- [ClinTox](https://tdcommons.ai/single_pred_tasks/tox/#clintox) — Clinical toxicity dataset contrasting FDA-approved drugs with those that failed clinical trials due to toxicity.
|
||||
- [CPTAC (Clinical Proteomic Tumor Analysis Consortium)](https://proteomics.cancer.gov/programs/cptac) — Multi-omic proteogenomic datasets for multiple cancer types linking proteomics with genomics.
|
||||
- [CrossDocked2020](https://arxiv.org/abs/2001.01037) — Large-scale dataset for structure-based virtual screening.
|
||||
- [DUD-E (Directory of Useful Decoys, Enhanced)](http://dude.docking.org/) — Structure-based virtual screening benchmark with active ligands and challenging decoy sets across diverse protein targets.
|
||||
- [FLIP (Fitness Landscape Inference for Proteins)](https://github.com/J-SNACKKB/FLIP) — Benchmark collection of protein fitness landscape datasets for evaluating protein ML models.
|
||||
- [Genomics of Drug Sensitivity in Cancer (GDSC)](https://www.cancerrxgene.org/) — Drug sensitivity for ~1000 human cancer cell lines and hundreds of compounds.
|
||||
- [GuacaMol](https://github.com/BenevolentAI/guacamol) — Benchmark suite for generative molecular design models.
|
||||
- [JUMP Cell Painting Datasets](https://github.com/jump-cellpainting/datasets) — Consortium-scale cell imaging perturbation datasets (chemical and genetic) for phenotypic profiling and drug discovery research.
|
||||
- [LINCS L1000](https://lincsproject.org/LINCS/tools/workflows/find-the-best-place-to-obtain-the-lincs-l1000-data) — Gene expression profiles (978 landmark genes) for >20,000 chemical and genetic perturbations across cell lines.
|
||||
- [MoleculeNet](http://moleculenet.ai/) — Benchmark datasets for molecular machine learning.
|
||||
- [MOSES](https://github.com/molecularsets/moses) — Benchmarking platform for molecular generation models.
|
||||
- [NCI60](https://dtp.cancer.gov/discovery_development/nci-60/) — Drug sensitivity benchmark across 60 diverse human cancer cell lines.
|
||||
- [OGB (Open Graph Benchmark)](https://ogb.stanford.edu/) — Large-scale graph ML benchmark suite including biological datasets such as ogbl-ppa (protein-protein associations) and ogbg-molhiv.
|
||||
- [OpenBioLink](https://github.com/OpenBioLink/OpenBioLink) — Benchmark datasets for biological knowledge graph completion.
|
||||
- [PharmGKB](https://www.pharmgkb.org/) — Curated pharmacogenomics dataset linking genetic variants to drug response phenotypes across thousands of drugs.
|
||||
- [PK-DB](https://pk-db.com/) — Open database of experimental pharmacokinetics (PK) and ADME data from clinical and preclinical studies.
|
||||
- [PRISM](https://depmap.org/portal/prism/) — Cancer drug sensitivity profiling of >4,500 drugs across >900 cancer cell lines using pooled-cell-line barcoding.
|
||||
- [ProteinGym](https://github.com/OATML-Markslab/ProteinGym) — Large-scale benchmark of deep mutational scanning assays for evaluating protein fitness landscape models.
|
||||
- [QM9](https://figshare.com/collections/Quantum_chemistry_structures_and_properties_of_134_kilo_molecules/978904) — Quantum chemistry properties for 134K stable small organic molecules computed at DFT level.
|
||||
- [scIB (Single-cell Integration Benchmarks)](https://github.com/theislab/scib) — Comprehensive benchmarking framework for single-cell data integration methods.
|
||||
- [scPerturb](https://github.com/sanderlab/scPerturb) — Curated and continuously updated single-cell perturbation data resource spanning CRISPR and drug perturbation studies.
|
||||
- [SIDER (Side Effect Resource)](http://sideeffects.embl.de/) — Database of 1,430 approved drugs with their recorded adverse drug reactions across 27 system-organ classes.
|
||||
- [Tabula Muris](https://tabula-muris.ds.czbiohub.org/) — Comprehensive single-cell atlas of 20 mouse organs and tissues, enabling cross-tissue and cross-species comparisons.
|
||||
- [Tabula Sapiens](https://tabula-sapiens-portal.ds.czbiohub.org/) — Comprehensive human single-cell atlas of ~500K cells from 24 organs and tissues across multiple donors.
|
||||
- [TAPE (Tasks Assessing Protein Embeddings)](https://github.com/songlab-cal/tape) — Benchmark suite of five biologically meaningful semi-supervised learning tasks for evaluating protein representations.
|
||||
- [The Cancer Genome Atlas (TCGA)](https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga) — Comprehensive multi-omics (genomics, transcriptomics, proteomics, methylation) dataset for 33 cancer types across ~11,000 patients.
|
||||
- [TCGA virtual spatial transcriptomics atlas](https://huggingface.co/datasets/ratschlab/TCGA_virtual_spatial_transcriptomics_atlas) — DeepSpot-M predicted transcriptome-wide ST for TCGA H&E (FF + FFPE; 28,664 slides / 32 cancer types; gated). Paper: [DeepSpot-M](https://www.medrxiv.org/content/10.64898/2026.06.19.26356060v1).
|
||||
- [HEST Xenium virtual spatial transcriptomics](https://huggingface.co/datasets/ratschlab/HEST_Xenium_virtual_spatial_transcriptomics) — DeepSpot-M predicted transcriptome-wide ST for 59 HEST-1k 10x Xenium samples (~13.3M cells) (gated). Paper: [DeepSpot-M](https://www.medrxiv.org/content/10.64898/2026.06.19.26356060v1).
|
||||
- [Therapeutics Data Commons (TDC)](https://tdcommons.ai/) — Unified benchmark suite covering ADMET, drug-target interaction, drug response, and more.
|
||||
- [Tox21](https://tripod.nih.gov/tox21/challenge/) — 12,707 compounds tested in 12 nuclear receptor and stress-response pathway biochemical assays for toxicity prediction.
|
||||
|
||||
### Genomics, Cancer & Biomedical Cohorts
|
||||
|
||||
- [1000 Genomes Project](https://www.internationalgenome.org/) — Reference panel of human genetic variation from 2,504 individuals across 26 populations.
|
||||
- [CPTAC (Clinical Proteomic Tumor Analysis Consortium)](https://proteomics.cancer.gov/programs/cptac) — Multi-omic proteogenomic datasets for multiple cancer types linking proteomics with genomics.
|
||||
- [The Cancer Genome Atlas (TCGA)](https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga) — Comprehensive multi-omics (genomics, transcriptomics, proteomics, methylation) dataset for 33 cancer types across ~11,000 patients.
|
||||
- [UK Biobank](https://www.ukbiobank.ac.uk/) — Large-scale biomedical database of ~500K participants with genetic, imaging, and health data for population genetics and disease studies.
|
||||
|
||||
### General Biological ML & Knowledge Graph Benchmarks
|
||||
|
||||
- [OGB (Open Graph Benchmark)](https://ogb.stanford.edu/) — Large-scale graph ML benchmark suite including biological datasets such as ogbl-ppa (protein-protein associations) and ogbg-molhiv.
|
||||
- [OpenBioLink](https://github.com/OpenBioLink/OpenBioLink) — Benchmark datasets for biological knowledge graph completion.
|
||||
|
||||
---
|
||||
|
||||
## API
|
||||
@@ -344,6 +398,11 @@ Browse and search the resources via the [GitHub Pages UI](https://inoue0426.gith
|
||||
- [TGSA](https://github.com/violet-sto/TGSA) — Tumor gene set and attention-based model leveraging biological pathway knowledge for drug response prediction.
|
||||
- [HiDRA](https://github.com/bsml320/HiDRA) — Hierarchical network model incorporating gene and pathway-level information for cancer drug response prediction.
|
||||
- [DRUML](https://github.com/CutillasLab/DRUMLR) — Ensemble machine learning framework combining standard ML with deep learning to systematically rank anti-cancer drugs from proteomics and RNA-seq data.
|
||||
- [PASO](https://github.com/queryang/PASO) — Pathway-aware multi-omics drug response model combining pathway-difference features, multi-scale convolutions, Transformer encoding, and drug SMILES.
|
||||
- [DTLCDR](https://doi.org/10.1016/j.jpha.2025.101315) — Target-based multimodal framework for preclinical cancer drug response prediction and transfer to clinical response, with explicit unseen-drug generalization.
|
||||
- [THERAPI](https://github.com/Sunginyoung/THERAPI) — Cell-line-to-patient transfer framework that aligns tumor transcriptomes with cancer cell lines and integrates perturbation and gene-level representations for patient drug response prediction.
|
||||
- [EXPRESSO](https://doi.org/10.1158/0008-5472.CAN-25-5220) — Supervised treatment-response framework using pretreatment tumor transcriptomics, drug targets, and context-specific biomarkers across multiple cancer types and therapies.
|
||||
- [PerturbRx](https://arxiv.org/abs/2608.21349) — Treatment-conditioned representation learning framework that transfers drug-induced latent transitions learned from single-cell perturbation data to patient-level cancer treatment-response prediction.
|
||||
|
||||
#### Drug Perturbation
|
||||
|
||||
@@ -352,6 +411,16 @@ Browse and search the resources via the [GitHub Pages UI](https://inoue0426.gith
|
||||
- [chemCPA](https://github.com/theislab/chemCPA) — Compositional perturbation autoencoder for predicting single-cell transcriptional responses to unseen drug perturbations and dose combinations.
|
||||
- [cycleCDR](https://github.com/hliulab/cycleCDR) — Interpretable cycle-consistency framework for modeling cellular responses to drug perturbations.
|
||||
- [PRNet](https://github.com/Perturbation-Response-Prediction/PRnet) — Deep generative model for predicting transcriptional responses to novel chemical perturbations for drug discovery.
|
||||
- [Bison](https://arxiv.org/abs/2609.32467) — Cross-dataset model for globally unseen-compound response prediction using a shared gene representation, discrete diffusion models, and matched drug-contrast supervision.
|
||||
- [biolord](https://github.com/nitzanlab/biolord) — Deep generative model that disentangles known and unknown attributes for conditional generation of single-cell states.
|
||||
- [PerturbNet](https://github.com/welch-lab/PerturbNet) — Conditional generative model for predicting distributions of single-cell states under unseen chemical and genetic perturbations.
|
||||
- [CellFlow](https://github.com/theislab/CellFlow) — Conditional flow-matching framework for modeling and predicting cellular phenotypes under chemical, genetic, and other perturbations.
|
||||
- [Prophet](https://github.com/theislab/prophet) — Transformer model for predicting cellular phenotypes under unseen chemical or genetic perturbations across heterogeneous assays and contexts.
|
||||
- [PrePR-CT](https://github.com/reem12345/Cell-Type-Specific-Graphs) — Graph-based model using cell-type-specific co-expression networks as inductive priors for small-data chemical perturbation response prediction.
|
||||
- [XPert](https://github.com/GSanShui/XPert) — Knowledge-informed dual-branch Transformer for drug-induced transcriptional perturbation prediction across dose, time, and cellular context.
|
||||
- [State](https://github.com/ArcInstitute/state) — Transition model for predicting cellular perturbation responses across diverse contexts and sets of cells.
|
||||
- [TxPert](https://github.com/valence-labs/TxPert) — Knowledge-graph-informed latent-transfer model for transcriptomic perturbation prediction across unseen single perturbations, combinations, and cross-context settings.
|
||||
- [LPM](https://github.com/perturblib/perturblib) — Large perturbation model that jointly learns heterogeneous perturbation experiments by disentangling perturbation, readout, and context representations.
|
||||
|
||||
#### Drug Repurposing
|
||||
|
||||
@@ -396,11 +465,45 @@ Browse and search the resources via the [GitHub Pages UI](https://inoue0426.gith
|
||||
- [GeneGPT](https://github.com/ncbi/GeneGPT) — LLM for biomedical information, integrated with various APIs.
|
||||
- [GenePT](https://github.com/yiqunchen/GenePT) — Foundation LLM for single-cell data.
|
||||
- [scPRINT](https://github.com/cantinilab/scPRINT) — Pretrained on 50M cells for scRNA-seq denoising & zero imputation.
|
||||
- [ClawBio](https://github.com/ClawBio/ClawBio) — Bioinformatics-native AI agent skill library with local-first pharmacogenomics, ancestry PCA, semantic similarity, nutrigenomics, and metagenomics skills.
|
||||
- [BioMedLM](https://huggingface.co/stanford-crfm/BioMedLM) — 2.7B parameter GPT-2-style language model trained exclusively on biomedical literature from PubMed for biomedical question answering and text generation.
|
||||
- [MolT5](https://github.com/blender-nlp/MolT5) — Language model for molecular tasks bridging text and SMILES, enabling molecule captioning and text-driven molecule generation.
|
||||
- [ChatDrug](https://github.com/chao1224/ChatDrug) — LLM-based conversational pipeline for drug discovery, using natural language prompts for iterative drug editing and optimization.
|
||||
- [CASSIA](https://github.com/ElliotXie/CASSIA) — Multi-agent LLM for reference-free, interpretable cell-type annotation of single-cell RNA-seq data, with dedicated annotation, validation, scoring, and reporting agents.
|
||||
|
||||
### Agentic AI for Biology
|
||||
|
||||
#### General Biomedical Agents
|
||||
|
||||
- [Biomni](https://github.com/snap-stanford/Biomni) — General-purpose biomedical AI agent integrating planning, code execution, specialized tools, databases, and software across diverse biomedical research tasks.
|
||||
- [ToolUniverse](https://github.com/mims-harvard/ToolUniverse) — Unified scientific tool ecosystem for building AI scientists that can discover, select, and execute biomedical tools and databases.
|
||||
- [ClawBio](https://github.com/ClawBio/ClawBio) — Bioinformatics-native AI agent skill library with local-first pharmacogenomics, ancestry PCA, semantic similarity, nutrigenomics, and metagenomics skills.
|
||||
- [BioMedAgent](https://github.com/BOBQWERA/BioMedAgent) — Self-evolving multi-agent framework for autonomous biomedical data analysis with tool discovery, workflow planning, code generation, execution, correction, and cross-omics analysis.
|
||||
- [BioMaster](https://github.com/ai4nucleome/BioMaster) — Multi-agent system for automated and auditable bioinformatics workflows spanning RNA-seq, ChIP-seq, single-cell, spatial omics, Hi-C, long reads, metagenomics, and proteomics.
|
||||
- [BRAD](https://github.com/Jpickard1/BRAD) — Retrieval-augmented bioinformatics assistant integrating scientific literature, databases, external tools, and executable workflows.
|
||||
|
||||
#### Therapeutics & Drug Discovery Agents
|
||||
|
||||
- [TxAgent](https://github.com/mims-harvard/TxAgent) — Therapeutic reasoning agent using multi-step reasoning and a large scientific tool universe for drug interactions, contraindications, and personalized treatment analysis.
|
||||
- [Medea](https://github.com/mims-harvard/Medea) — Multi-agent therapeutic discovery system combining research planning, biological data analysis, literature reasoning, and multi-LLM deliberation across single-cell, cell-line, and patient contexts.
|
||||
- [DrugAgent](https://github.com/inoue0426/DrugAgent) — Multi-agent biomedical evidence synthesis framework for computational drug discovery with reliability-aware aggregation.
|
||||
|
||||
#### Bioinformatics & Omics Agents
|
||||
|
||||
- [CASSIA](https://github.com/ElliotXie/CASSIA) — Multi-agent LLM framework for reference-free and interpretable single-cell cell-type annotation with dedicated annotation, validation, scoring, and reporting agents.
|
||||
- [STELLA](https://github.com/zaixizhang/STELLA) — Self-evolving biomedical research agent that expands its tool repertoire and supports literature reasoning, computational analysis, and laboratory-oriented scientific workflows.
|
||||
- [AutoBA](https://github.com/JoshuaChou2018/AutoBA) — Automated multi-omics analysis agent that plans, executes, and repairs bioinformatics workflows from natural-language objectives.
|
||||
- [GenoMAS](https://github.com/Liu-Hy/GenoMAS) — Multi-agent framework for code-driven gene-expression analysis with planning, execution, debugging, backtracking, and GEO/TCGA-based scientific discovery.
|
||||
- [BIA](https://github.com/biagent-dev/bia) — Bioinformatics agent for GEO search, sample metadata extraction, count-matrix processing, and pipeline extraction from papers.
|
||||
- [BioAgents](https://github.com/microsoft/bioinformagus) — Multi-agent bioinformatics assistant using specialized language models and retrieval for genomics workflow development and troubleshooting.
|
||||
- [Genomi](https://github.com/exon-research/genomi) — Local-first genomics agent runtime that indexes personal variants, queries evidence, and generates evidence-grounded reports while keeping raw genome data on-device.
|
||||
|
||||
#### Multi-Agent Scientific Labs
|
||||
|
||||
- [Virtual Lab](https://github.com/zou-group/virtual-lab) — Human–AI collaborative research environment in which an LLM principal investigator coordinates specialized scientist agents for scientific discovery.
|
||||
- [Agent Laboratory](https://github.com/SamuelSchmidgall/AgentLaboratory) — End-to-end multi-agent research workflow for literature review, experimentation, implementation, analysis, and report generation.
|
||||
|
||||
#### Paper & Workflow Agents
|
||||
|
||||
- [Paper2Agent](https://github.com/jmiao24/Paper2Agent) — Multi-agent system that transforms research papers and associated code into interactive, testable scientific agents and MCP tools.
|
||||
|
||||
### Foundation Models
|
||||
|
||||
@@ -418,6 +521,8 @@ Browse and search the resources via the [GitHub Pages UI](https://inoue0426.gith
|
||||
- [GEARS](https://github.com/snap-stanford/GEARS) — Graph-based model for predicting transcriptional responses to single and combinatorial genetic perturbations using biological priors.
|
||||
- [SATURN](https://github.com/snap-stanford/SATURN) — Transformer-based model integrating gene expression and protein sequences via a protein language model to learn unified multi-species cell embeddings.
|
||||
- [CancerFoundation](https://github.com/BoevaLab/CancerFoundation) — Single-cell RNA-seq foundation model trained exclusively on a curated dataset of malignant cells to learn cancer-specific embeddings.
|
||||
- [CellFM](https://github.com/biomed-AI/CellFM) — 800M-parameter single-cell foundation model pretrained on transcriptomics from 100 million human cells for annotation, integration, gene-function, and perturbation tasks.
|
||||
- [scPRINT-2](https://github.com/cantinilab/scPRINT-2) — Next-generation single-cell foundation model pretrained on 350M+ cells across 22K+ datasets and 16 species for embeddings, denoising, annotation, gene-network inference, and cross-species transfer.
|
||||
|
||||
##### Spatial Foundation Models
|
||||
|
||||
@@ -432,6 +537,16 @@ Browse and search the resources via the [GitHub Pages UI](https://inoue0426.gith
|
||||
- [DeepSpot-M](https://github.com/ratschlab/DeepSpotM) — Multimodal foundation model for transcriptome-wide virtual spatial transcriptomics from histology.
|
||||
- [AESTETIK](https://github.com/ratschlab/aestetik) — Autoencoder for spatial transcriptomics representation learning using topology and histology image knowledge.
|
||||
|
||||
##### Pathology Foundation Models
|
||||
|
||||
- [TITAN](https://github.com/mahmoodlab/TITAN) — Multimodal whole-slide pathology foundation model that combines image and language supervision for slide-level representation and zero-shot analysis.
|
||||
- [Virchow2](https://huggingface.co/paige-ai/Virchow2) — 632M-parameter pathology vision transformer pretrained on 3.1M whole-slide images with mixed-magnification self-supervision.
|
||||
- [H-Optimus-0](https://huggingface.co/bioptimus/H-optimus-0) — 1.1B-parameter histopathology foundation model trained with self-supervised learning on a large multi-center slide corpus.
|
||||
- [H-Optimus-1](https://huggingface.co/bioptimus/H-optimus-1) — 1.1B-parameter pathology foundation model trained on billions of histology images from more than one million slides and 800K+ patients.
|
||||
- [UNI2-h](https://huggingface.co/MahmoodLab/UNI2-h) — Billion-parameter histopathology vision foundation model for tile-level feature extraction and downstream computational pathology tasks.
|
||||
- [Phikon-v2](https://huggingface.co/owkin/phikon-v2) — Updated pathology foundation model for general-purpose histology feature extraction and transfer learning.
|
||||
- [GenBio-PathFM](https://github.com/genbio-ai/genbio-pathfm) — 1.1B-parameter histopathology foundation model trained on public data using morphology-aware curation and dual-stage JEPA+DINO learning.
|
||||
|
||||
##### Multi-Omics Foundation Models
|
||||
|
||||
- [scMulan](https://github.com/SuperBianC/scMulan) — Single-cell multi-omic language model pretrained on ~10M cells spanning transcriptomics, epigenomics, and proteomics for cross-omics transfer tasks.
|
||||
@@ -465,6 +580,8 @@ Browse and search the resources via the [GitHub Pages UI](https://inoue0426.gith
|
||||
- [Mol2Vec](https://github.com/samoturk/mol2vec) — Unsupervised molecular embedding method inspired by Word2Vec for learning vector representations of chemical substructures.
|
||||
- [MolFormer](https://github.com/IBM/molformer) — Linear attention transformer pretrained on millions of SMILES strings for efficient molecular embeddings.
|
||||
- [Uni-Mol](https://github.com/deepmodeling/Uni-Mol) — 3D molecular pretraining framework for universal representation learning on molecules and protein pockets.
|
||||
- [Uni-Mol2](https://github.com/deepmodeling/Uni-Mol/tree/main/unimol2) — Scaled molecular pretraining model using atomic, graph, and 3D geometry features, with models up to 1.1B parameters pretrained on 800M conformations.
|
||||
- [ChemFM](https://github.com/TheLuoFengLab/ChemFM) — 1B/3B-parameter chemical language model pretrained on 178M molecules for molecular representation, property prediction, generation, and synthesis tasks.
|
||||
|
||||
#### Protein Foundation Models
|
||||
|
||||
@@ -474,11 +591,14 @@ Browse and search the resources via the [GitHub Pages UI](https://inoue0426.gith
|
||||
- [ProtTrans](https://github.com/agemagician/ProtTrans) — Suite of protein language models (ProtBERT, ProtT5, ProtXLNet) trained on billions of protein sequences from UniRef and BFD.
|
||||
- [ProGen2](https://github.com/salesforce/progen) — Protein language model trained on diverse protein families for sequence generation and fitness prediction.
|
||||
- [Ankh](https://github.com/agemagician/Ankh) — Efficient protein language model optimized for downstream prediction tasks including secondary structure, localization, and function annotation.
|
||||
- [ESM Cambrian (ESM C)](https://github.com/Biohub/esm) — Protein representation foundation-model family designed as an efficient next-generation successor to ESM2, spanning 300M to multi-billion-parameter models.
|
||||
|
||||
##### Protein Structure Prediction and Design
|
||||
|
||||
- [AlphaFold3](https://github.com/google-deepmind/alphafold3) — Predicts structures of proteins, nucleic acids, small molecules, and their complexes.
|
||||
- [Boltz-1](https://github.com/jwohlwend/boltz) — Open-source all-atom biomolecular structure prediction model for proteins, nucleic acids, small molecules, and their complexes achieving AlphaFold3-level accuracy.
|
||||
- [Boltz-2](https://github.com/jwohlwend/boltz) — Biomolecular foundation model jointly predicting complex structures and binding affinities for protein–ligand interaction modeling and virtual screening.
|
||||
- [Protenix](https://github.com/bytedance/Protenix) — Trainable biomolecular structure-prediction framework for proteins, nucleic acids, ligands, and complexes with open training and inference pipelines.
|
||||
- [Chai-1](https://github.com/chaidiscovery/chai-lab) — Unified molecular structure prediction model covering proteins, nucleic acids, small molecules, and complexes.
|
||||
- [ESM3](https://github.com/evolutionaryscale/esm) — Multimodal protein language model that jointly reasons over sequence, structure, and function for generative protein design and engineering.
|
||||
- [ESMFold](https://github.com/facebookresearch/esm) — Fast protein structure prediction using language model embeddings.
|
||||
@@ -501,6 +621,36 @@ Browse and search the resources via the [GitHub Pages UI](https://inoue0426.gith
|
||||
- [PLIP](https://github.com/PathologyFoundation/plip) — Vision-language foundation model for pathology trained with contrastive learning on pathology image–text pairs for image classification and text-to-image retrieval.
|
||||
- [MUSK](https://github.com/lilab-stanford/MUSK) — Vision-language foundation model for precision oncology analyzing multimodal paired text and pathology image data for biomarker prediction and retrieval.
|
||||
|
||||
#### Cancer Genome Foundation Models
|
||||
|
||||
- [TESSERA](https://github.com/JW-Sidhom-Lab/tessera) — Cancer-genome foundation model jointly pretrained on somatic SNVs and copy-number alterations from TCGA using masked reconstruction and cross-modal contrastive learning.
|
||||
- [MutationProjector](https://doi.org/10.1101/2025.09.08.674723) — Pan-cancer genotype foundation model trained on mutations and copy-number alterations from >30K tumors for clinical representation learning.
|
||||
|
||||
#### Single-Cell Epigenomics Foundation Models
|
||||
|
||||
- [EpiAgent](https://github.com/xy-chen16/EpiAgent) — scATAC-seq foundation model pretrained on ~5M cells and >35B tokens for representation learning, annotation, imputation, perturbation prediction, and in-silico cCRE knockout.
|
||||
- [SCARF](https://doi.org/10.1101/2025.04.07.647689) — Single-cell RNA+ATAC foundation model pretrained on >2.7M cells for multimodal representation, matching, cross-omics translation, and few-shot annotation.
|
||||
- [scDNAm-GPT](https://github.com/ChaoqiLiang/scDNAm-GPM) — Foundation model for single-cell whole-genome bisulfite sequencing with whole-genome context modeling at single-CpG resolution.
|
||||
- [EpiFoundation](https://doi.org/10.1101/2025.02.05.636688) — Foundation model for scATAC-seq using peak-to-gene aligned pretraining for cell representation, annotation, batch correction, and gene-expression prediction.
|
||||
- [ChromFound](https://github.com/SAIS-LifeScience/ChromFound) — Genome-aware scATAC-seq foundation model pretrained on 1.97M cells across tissues and disease contexts for zero-shot cell representations, annotation, and cross-omics prediction.
|
||||
- [Atacformer](https://doi.org/10.1101/2025.11.03.685753) — Transformer foundation model for scATAC-seq that learns embeddings of cis-regulatory elements for clustering, annotation, and reference mapping.
|
||||
- [CLM-X](https://doi.org/10.64898/2026.02.17.704943) — Multi-way Transformer foundation model jointly handling RNA-only, ATAC-only, and paired RNA–ATAC single-cell inputs for integration, translation, annotation, and perturbation prediction.
|
||||
|
||||
#### Other Omics Foundation Models
|
||||
|
||||
- [CAPTAIN](https://doi.org/10.1038/s41467-026-72882-y) — Multimodal foundation model pretrained on co-assayed single-cell RNA and protein for joint representation learning and cross-modal downstream tasks.
|
||||
- [HiCFoundation](https://doi.org/10.1038/s41592-026-03097-8) — Hi-C foundation model pretrained on large-scale chromatin-contact maps for 3D-genome analysis, epigenomic prediction, and single-cell Hi-C adaptation.
|
||||
- [OmicsFM](https://github.com/CompOmics/OmicsFM) — Modality-agnostic molecular-expression foundation model with matched proteomics, bulk-transcriptomics, and single-cell-transcriptomics checkpoints.
|
||||
- [VirTues](https://github.com/bunnelab/virtues) — Spatial-proteomics foundation model learning marker-aware representations across proteins, cells, niches, and tissues from multiplexed imaging.
|
||||
- [MethylGPT](https://github.com/albert-ying/MethylGPT) — Transformer foundation model for DNA methylation pretrained on >150K human methylomes across thousands of datasets, with 3M/7M/15M parameter variants.
|
||||
- [CpGPT](https://github.com/lucascamillomd/CpGPT) — DNA methylation foundation model pretrained on >150K samples for zero-shot imputation, array conversion, reference mapping, and downstream phenotype prediction.
|
||||
- [Casanovo Foundation](https://github.com/Noble-Lab/casanovo-tl) — Tandem mass-spectrometry proteomics foundation model that reuses a pretrained Casanovo spectrum encoder for spectrum quality, chimericity, and post-translational-modification prediction.
|
||||
|
||||
#### RNA Foundation Models
|
||||
|
||||
- [RNA-FM](https://github.com/ml4bio/RNA-FM) — General-purpose RNA foundation model pretrained on large-scale RNA sequences for structural and functional representation learning.
|
||||
- [RiNALMo](https://github.com/lbcb-sci/RiNALMo) — RNA language-model family pretrained on tens of millions of RNA sequences for secondary-structure and functional prediction tasks.
|
||||
|
||||
#### Genomics Foundation Models
|
||||
|
||||
- [Nucleotide Transformer](https://github.com/instadeepai/nucleotide-transformer) — Foundation model for genomic sequences across multiple species.
|
||||
@@ -510,6 +660,9 @@ Browse and search the resources via the [GitHub Pages UI](https://inoue0426.gith
|
||||
- [Basenji](https://github.com/calico/basenji) — Sequential regulatory activity prediction from DNA sequences.
|
||||
- [Caduceus](https://github.com/kuleshov-group/caduceus) — Bidirectional equivariant long-range DNA sequence model based on Mamba.
|
||||
- [Evo](https://github.com/evo-design/evo) — Long-context genomic foundation model (up to 1M tokens).
|
||||
- [Evo 2](https://github.com/arcinstitute/evo2) — Genome foundation model trained on 9 trillion DNA base pairs across all domains of life with a 1M-token context window and single-nucleotide resolution.
|
||||
- [AlphaGenome](https://github.com/google-deepmind/alphagenome) — Long-context DNA model predicting multimodal regulatory outputs including expression, splicing, chromatin features, and contact maps at near base-pair resolution.
|
||||
- [modernGENA](https://github.com/AIRI-Institute/GENA_LM) — ModernBERT-style DNA foundation-model family pretrained on hundreds of vertebrate genome assemblies for efficient long-sequence regulatory modeling.
|
||||
- [HyenaDNA](https://github.com/HazyResearch/hyena-dna) — Long-range genomic foundation model handling sequences up to 1M tokens with sub-quadratic attention.
|
||||
- [Borzoi](https://github.com/calico/borzoi) — Extended successor to Enformer for predicting RNA-seq coverage from long genomic sequence windows (524 kb) with improved resolution.
|
||||
- [DeepSEA](http://deepsea.princeton.edu/) — Deep learning framework for predicting chromatin effects of sequence alterations with single-nucleotide sensitivity across thousands of chromatin features.
|
||||
|
||||
@@ -2,9 +2,9 @@
|
||||
title: "Cspell"
|
||||
task: ""
|
||||
lineage_type: import
|
||||
upstream_source: https://github.com/inoue0426/awesome-computational-biology/blob/c6f07d90/cspell.json
|
||||
upstream_sha: c6f07d90
|
||||
imported_at: 2026-08-31
|
||||
upstream_source: https://github.com/inoue0426/awesome-computational-biology/blob/4ed7cfef/cspell.json
|
||||
upstream_sha: 4ed7cfef
|
||||
imported_at: 2026-10-26
|
||||
prompt_class: unknown
|
||||
upstream_changes: accepted
|
||||
author: upstream
|
||||
@@ -15,166 +15,249 @@ validated: false
|
||||
"language": "en",
|
||||
"allowCompoundWords": true,
|
||||
"words": [
|
||||
"behavioural",
|
||||
"KEGG",
|
||||
"NCBI",
|
||||
"UCSC",
|
||||
"EMBL",
|
||||
"RCSB",
|
||||
"CASP",
|
||||
"Uniclust",
|
||||
"Reactome",
|
||||
"Bioactive",
|
||||
"biopolymers",
|
||||
"proteomics",
|
||||
"transcriptomics",
|
||||
"metagenomic",
|
||||
"metatranscriptomic",
|
||||
"CRISPR",
|
||||
"JASPAR",
|
||||
"druggable",
|
||||
"Toxicogenomics",
|
||||
"GDSC",
|
||||
"biomolecular",
|
||||
"DRKG",
|
||||
"Hetionet",
|
||||
"Eudra",
|
||||
"esearch",
|
||||
"efetch",
|
||||
"Ensembl",
|
||||
"Cheminformatics",
|
||||
"Deconv",
|
||||
"Scanpy",
|
||||
"Squidpy",
|
||||
"explainability",
|
||||
"MOFGCN",
|
||||
"Autoencoder",
|
||||
"DGDRP",
|
||||
"MCPINN",
|
||||
"Pretrained",
|
||||
"pretrained",
|
||||
"denoising",
|
||||
"transcriptomic",
|
||||
"CELLxGENE",
|
||||
"eukaryotic",
|
||||
"metabolites",
|
||||
"OMIM",
|
||||
"OncoKB",
|
||||
"Mendelian",
|
||||
"DisGeNET",
|
||||
"GWAS",
|
||||
"IntAct",
|
||||
"Biopython",
|
||||
"MDAnalysis",
|
||||
"trajectories",
|
||||
"Geneformer",
|
||||
"equivariant",
|
||||
"HyenaDNA",
|
||||
"Hyena",
|
||||
"Caduceus",
|
||||
"Mamba",
|
||||
"retrosynthesis",
|
||||
"TargetDiff",
|
||||
"Chai",
|
||||
"Zuckerberg",
|
||||
"HMDB",
|
||||
"CTRP",
|
||||
"Adamson",
|
||||
"ADME",
|
||||
"ADMET",
|
||||
"Omics",
|
||||
"omics",
|
||||
"omic",
|
||||
"OADB",
|
||||
"AESTETIK",
|
||||
"AlphaGenome",
|
||||
"Ankh",
|
||||
"ATAC",
|
||||
"Atacformer",
|
||||
"AutoBA",
|
||||
"Autoencoder",
|
||||
"BACE",
|
||||
"behavioural",
|
||||
"Bento",
|
||||
"Bioactive",
|
||||
"BioAgents",
|
||||
"biolord",
|
||||
"BioMaster",
|
||||
"BioMedAgent",
|
||||
"Biomni",
|
||||
"biomolecular",
|
||||
"biopolymers",
|
||||
"Biopython",
|
||||
"Bison",
|
||||
"Boltz",
|
||||
"bowang",
|
||||
"Caduceus",
|
||||
"Cambrian",
|
||||
"Casanovo",
|
||||
"CASP",
|
||||
"CASSIA",
|
||||
"CellFlow",
|
||||
"CellFM",
|
||||
"CellOT",
|
||||
"CELLxGENE",
|
||||
"Chai",
|
||||
"ChatDrug",
|
||||
"Chem",
|
||||
"ChemFM",
|
||||
"Cheminformatics",
|
||||
"chimericity",
|
||||
"Chrom",
|
||||
"ChromFound",
|
||||
"CITE-seq",
|
||||
"ClawBio",
|
||||
"Clin",
|
||||
"CMonge",
|
||||
"convolutional",
|
||||
"CpGPT",
|
||||
"CPTAC",
|
||||
"CRISPR",
|
||||
"CRISPRa",
|
||||
"CRISPRi",
|
||||
"CROP",
|
||||
"ctheodoris",
|
||||
"CTRP",
|
||||
"Datlinger",
|
||||
"Deconv",
|
||||
"deconvolution",
|
||||
"DeepSEA",
|
||||
"denoising",
|
||||
"DGDRP",
|
||||
"DisGeNET",
|
||||
"Dixit",
|
||||
"DoubletFinder",
|
||||
"DRKG",
|
||||
"druggable",
|
||||
"DRUML",
|
||||
"DTLCDR",
|
||||
"efetch",
|
||||
"EMBL",
|
||||
"Enformer",
|
||||
"Ensembl",
|
||||
"EpiFoundation",
|
||||
"epigenome",
|
||||
"epigenomic",
|
||||
"epigenomics",
|
||||
"equivariant",
|
||||
"esearch",
|
||||
"Eudra",
|
||||
"eukaryotic",
|
||||
"explainability",
|
||||
"EXPRESSO",
|
||||
"FANTOM",
|
||||
"FCFP4",
|
||||
"FFPE",
|
||||
"finetunable",
|
||||
"Frangieh",
|
||||
"Gasperini",
|
||||
"GDSC",
|
||||
"GenBio",
|
||||
"Geneformer",
|
||||
"Geno",
|
||||
"GenoMAS",
|
||||
"Genomi",
|
||||
"Giga",
|
||||
"Gnify",
|
||||
"gnom",
|
||||
"Rfam",
|
||||
"GPN",
|
||||
"GPT",
|
||||
"Guaca",
|
||||
"deconvolution",
|
||||
"scvi",
|
||||
"pharmacogenomics",
|
||||
"nutrigenomics",
|
||||
"Giga",
|
||||
"Phikon",
|
||||
"TCGA",
|
||||
"Mulan",
|
||||
"epigenomics",
|
||||
"methylation",
|
||||
"ATAC",
|
||||
"MOFA",
|
||||
"TOSICA",
|
||||
"Boltz",
|
||||
"MPNN",
|
||||
"Enformer",
|
||||
"Velo",
|
||||
"BACE",
|
||||
"secretase",
|
||||
"Clin",
|
||||
"CPTAC",
|
||||
"Proteomic",
|
||||
"proteogenomic",
|
||||
"LINCS",
|
||||
"ogbl",
|
||||
"ogbg",
|
||||
"SIDER",
|
||||
"Muris",
|
||||
"Pfam",
|
||||
"PROSITE",
|
||||
"epigenome",
|
||||
"TRRUST",
|
||||
"kallisto",
|
||||
"pseudoalignment",
|
||||
"multiplet",
|
||||
"TGSA",
|
||||
"GWAS",
|
||||
"H-Optimus",
|
||||
"Haplotype",
|
||||
"Hetionet",
|
||||
"HiDRA",
|
||||
"HMDB",
|
||||
"Hyena",
|
||||
"HyenaDNA",
|
||||
"Imageomics",
|
||||
"IntAct",
|
||||
"JASPAR",
|
||||
"JEPA",
|
||||
"JTVAE",
|
||||
"Jurkat",
|
||||
"kallisto",
|
||||
"KEGG",
|
||||
"KIBA",
|
||||
"L1000",
|
||||
"ligand",
|
||||
"LINCS",
|
||||
"Mamba",
|
||||
"MCPINN",
|
||||
"MDAnalysis",
|
||||
"Medea",
|
||||
"Mendelian",
|
||||
"metabolites",
|
||||
"metagenomic",
|
||||
"metatranscriptomic",
|
||||
"methylation",
|
||||
"MethylGPT",
|
||||
"methylomes",
|
||||
"miRBase",
|
||||
"miRNA",
|
||||
"ProtTrans",
|
||||
"ProtBERT",
|
||||
"ProGen",
|
||||
"Ankh",
|
||||
"DeepSEA",
|
||||
"RegNetwork",
|
||||
"ROADMAP",
|
||||
"FANTOM",
|
||||
"NeXtProt",
|
||||
"HiDRA",
|
||||
"MolT",
|
||||
"ChatDrug",
|
||||
"DoubletFinder",
|
||||
"pseudotime",
|
||||
"ligand",
|
||||
"SCENIC",
|
||||
"GPN",
|
||||
"Sei",
|
||||
"KIBA",
|
||||
"pharmacokinetics",
|
||||
"ADME",
|
||||
"Haplotype",
|
||||
"NCEM",
|
||||
"multiome",
|
||||
"modernGENA",
|
||||
"MOFA",
|
||||
"MOFGCN",
|
||||
"MOGONET",
|
||||
"convolutional",
|
||||
"DRUML",
|
||||
"SBDD",
|
||||
"Pacc",
|
||||
"MolT",
|
||||
"Morgan",
|
||||
"MPNN",
|
||||
"Mulan",
|
||||
"multiome",
|
||||
"multiomics",
|
||||
"Pathomic",
|
||||
"PLIP",
|
||||
"Omni",
|
||||
"Bento",
|
||||
"FFPE",
|
||||
"Xenium",
|
||||
"Zyme",
|
||||
"Neur",
|
||||
"Imageomics",
|
||||
"AESTETIK",
|
||||
"CellOT",
|
||||
"CMonge",
|
||||
"bowang",
|
||||
"ctheodoris",
|
||||
"OpenAI",
|
||||
"GPT",
|
||||
"multiplet",
|
||||
"Muris",
|
||||
"MutationProjector",
|
||||
"nanobody",
|
||||
"thermostability"
|
||||
"NCBI",
|
||||
"NCEM",
|
||||
"Neur",
|
||||
"NeXtProt",
|
||||
"Novartis",
|
||||
"nutrigenomics",
|
||||
"OADB",
|
||||
"ogbg",
|
||||
"ogbl",
|
||||
"omic",
|
||||
"omics",
|
||||
"Omics",
|
||||
"OmicsFM",
|
||||
"OMIM",
|
||||
"Omni",
|
||||
"OncoKB",
|
||||
"OP3",
|
||||
"OpenAI",
|
||||
"Pacc",
|
||||
"Paper2Agent",
|
||||
"Pathomic",
|
||||
"Perturb",
|
||||
"Perturb-seq",
|
||||
"PerturbNet",
|
||||
"PerturBridge",
|
||||
"PerturbRx",
|
||||
"Pfam",
|
||||
"pharmacogenomics",
|
||||
"pharmacokinetics",
|
||||
"Phikon",
|
||||
"PLIP",
|
||||
"PrePR",
|
||||
"pretrained",
|
||||
"Pretrained",
|
||||
"ProGen",
|
||||
"PROSITE",
|
||||
"ProtBERT",
|
||||
"Protenix",
|
||||
"proteogenomic",
|
||||
"Proteomic",
|
||||
"proteomics",
|
||||
"ProtTrans",
|
||||
"pseudoalignment",
|
||||
"pseudobulk",
|
||||
"pseudotime",
|
||||
"RCSB",
|
||||
"RDKit",
|
||||
"Reactome",
|
||||
"RegNetwork",
|
||||
"Replogle",
|
||||
"retrosynthesis",
|
||||
"Rfam",
|
||||
"RiNALMo",
|
||||
"ROADMAP",
|
||||
"SBDD",
|
||||
"Scanpy",
|
||||
"SCENIC",
|
||||
"SciPlex",
|
||||
"scPRINT",
|
||||
"scrna",
|
||||
"scvi",
|
||||
"secretase",
|
||||
"Sei",
|
||||
"SIDER",
|
||||
"silico",
|
||||
"Squidpy",
|
||||
"State",
|
||||
"STELLA",
|
||||
"TargetDiff",
|
||||
"TCGA",
|
||||
"TGSA",
|
||||
"THERAPI",
|
||||
"thermostability",
|
||||
"TITAN",
|
||||
"ToolUniverse",
|
||||
"TOSICA",
|
||||
"Toxicogenomics",
|
||||
"trajectories",
|
||||
"transcriptomic",
|
||||
"transcriptomics",
|
||||
"TRRUST",
|
||||
"TxAgent",
|
||||
"TxPert",
|
||||
"UCSC",
|
||||
"Uni-Mol2",
|
||||
"UNI2",
|
||||
"Uniclust",
|
||||
"UniMol",
|
||||
"VCPI",
|
||||
"Velo",
|
||||
"Virchow2",
|
||||
"VirTues",
|
||||
"Xenium",
|
||||
"XPert",
|
||||
"Zuckerberg",
|
||||
"Zyme"
|
||||
],
|
||||
"ignorePaths": [
|
||||
"node_modules/**"
|
||||
|
||||
+298
@@ -0,0 +1,298 @@
|
||||
---
|
||||
title: "Agent Explorer v1 metadata."
|
||||
task: ""
|
||||
lineage_type: import
|
||||
upstream_source: https://github.com/inoue0426/awesome-computational-biology/blob/4ed7cfef/data/enrichment.agent-explorer-v1.yml
|
||||
upstream_sha: 4ed7cfef
|
||||
imported_at: 2026-10-26
|
||||
prompt_class: unknown
|
||||
upstream_changes: accepted
|
||||
author: upstream
|
||||
validated: false
|
||||
---
|
||||
|
||||
# Agent Explorer v1 metadata.
|
||||
resources:
|
||||
biomni:
|
||||
agent_profile:
|
||||
year: 2025
|
||||
domains: [general-biomedicine, bioinformatics, therapeutics, omics]
|
||||
architecture: single-agent
|
||||
tool_use: true
|
||||
code_execution: true
|
||||
web_retrieval: true
|
||||
literature: true
|
||||
omics: true
|
||||
wet_lab: limited
|
||||
autonomous_experiment: limited
|
||||
human_in_loop: true
|
||||
open_source: true
|
||||
|
||||
tooluniverse:
|
||||
agent_profile:
|
||||
year: 2025
|
||||
domains: [general-biomedicine, tool-ecosystem, therapeutics, bioinformatics]
|
||||
architecture: agent-ecosystem
|
||||
tool_use: true
|
||||
code_execution: limited
|
||||
web_retrieval: true
|
||||
literature: true
|
||||
omics: true
|
||||
wet_lab: limited
|
||||
autonomous_experiment: limited
|
||||
human_in_loop: true
|
||||
open_source: true
|
||||
|
||||
clawbio:
|
||||
agent_profile:
|
||||
year: 2026
|
||||
domains: [bioinformatics, genomics, pharmacogenomics, omics]
|
||||
architecture: agent-ecosystem
|
||||
tool_use: true
|
||||
code_execution: true
|
||||
web_retrieval: true
|
||||
literature: limited
|
||||
omics: true
|
||||
wet_lab: false
|
||||
autonomous_experiment: false
|
||||
human_in_loop: true
|
||||
open_source: true
|
||||
|
||||
txagent:
|
||||
agent_profile:
|
||||
year: 2025
|
||||
domains: [therapeutics, drug-discovery, precision-medicine]
|
||||
architecture: single-agent
|
||||
tool_use: true
|
||||
code_execution: limited
|
||||
web_retrieval: true
|
||||
literature: true
|
||||
omics: limited
|
||||
wet_lab: false
|
||||
autonomous_experiment: limited
|
||||
human_in_loop: true
|
||||
open_source: true
|
||||
|
||||
medea:
|
||||
agent_profile:
|
||||
year: 2025
|
||||
domains: [therapeutics, drug-discovery, single-cell, omics]
|
||||
architecture: multi-agent
|
||||
tool_use: true
|
||||
code_execution: true
|
||||
web_retrieval: true
|
||||
literature: true
|
||||
omics: true
|
||||
wet_lab: limited
|
||||
autonomous_experiment: limited
|
||||
human_in_loop: true
|
||||
open_source: true
|
||||
|
||||
drugagent:
|
||||
agent_profile:
|
||||
year: 2026
|
||||
domains: [drug-discovery, therapeutics, evidence-synthesis]
|
||||
architecture: multi-agent
|
||||
tool_use: true
|
||||
code_execution: limited
|
||||
web_retrieval: true
|
||||
literature: true
|
||||
omics: limited
|
||||
wet_lab: false
|
||||
autonomous_experiment: limited
|
||||
human_in_loop: true
|
||||
open_source: true
|
||||
|
||||
cassia:
|
||||
agent_profile:
|
||||
year: 2024
|
||||
domains: [single-cell, bioinformatics, omics]
|
||||
architecture: multi-agent
|
||||
tool_use: limited
|
||||
code_execution: limited
|
||||
web_retrieval: limited
|
||||
literature: true
|
||||
omics: true
|
||||
wet_lab: false
|
||||
autonomous_experiment: false
|
||||
human_in_loop: true
|
||||
open_source: true
|
||||
|
||||
stella:
|
||||
agent_profile:
|
||||
year: 2025
|
||||
domains: [general-biomedicine, bioinformatics, scientific-workflow]
|
||||
architecture: single-agent
|
||||
tool_use: true
|
||||
code_execution: true
|
||||
web_retrieval: true
|
||||
literature: true
|
||||
omics: limited
|
||||
wet_lab: limited
|
||||
autonomous_experiment: true
|
||||
human_in_loop: true
|
||||
open_source: true
|
||||
|
||||
virtual_lab:
|
||||
agent_profile:
|
||||
year: 2024
|
||||
domains: [scientific-workflow, protein-design, experimental-design]
|
||||
architecture: multi-agent
|
||||
tool_use: true
|
||||
code_execution: true
|
||||
web_retrieval: limited
|
||||
literature: true
|
||||
omics: limited
|
||||
wet_lab: true
|
||||
autonomous_experiment: limited
|
||||
human_in_loop: true
|
||||
open_source: true
|
||||
|
||||
agent_laboratory:
|
||||
agent_profile:
|
||||
year: 2025
|
||||
domains: [scientific-workflow, research-automation]
|
||||
architecture: multi-agent
|
||||
tool_use: true
|
||||
code_execution: true
|
||||
web_retrieval: true
|
||||
literature: true
|
||||
omics: false
|
||||
wet_lab: false
|
||||
autonomous_experiment: true
|
||||
human_in_loop: true
|
||||
open_source: true
|
||||
|
||||
paper2agent:
|
||||
agent_profile:
|
||||
year: 2025
|
||||
domains: [paper-to-agent, scientific-workflow, tool-generation]
|
||||
architecture: multi-agent
|
||||
tool_use: true
|
||||
code_execution: true
|
||||
web_retrieval: true
|
||||
literature: true
|
||||
omics: limited
|
||||
wet_lab: false
|
||||
autonomous_experiment: limited
|
||||
human_in_loop: true
|
||||
open_source: true
|
||||
|
||||
biomedagent:
|
||||
agent_profile:
|
||||
year: 2026
|
||||
domains: [general-biomedicine, bioinformatics, omics]
|
||||
architecture: multi-agent
|
||||
tool_use: true
|
||||
code_execution: true
|
||||
web_retrieval: limited
|
||||
literature: limited
|
||||
omics: true
|
||||
wet_lab: false
|
||||
autonomous_experiment: true
|
||||
human_in_loop: true
|
||||
open_source: true
|
||||
|
||||
biomaster:
|
||||
agent_profile:
|
||||
year: 2026
|
||||
domains: [bioinformatics, omics, scientific-workflow]
|
||||
architecture: multi-agent
|
||||
tool_use: true
|
||||
code_execution: true
|
||||
web_retrieval: limited
|
||||
literature: limited
|
||||
omics: true
|
||||
wet_lab: false
|
||||
autonomous_experiment: true
|
||||
human_in_loop: true
|
||||
open_source: true
|
||||
|
||||
brad:
|
||||
agent_profile:
|
||||
year: 2025
|
||||
domains: [bioinformatics, literature, scientific-workflow]
|
||||
architecture: single-agent
|
||||
tool_use: true
|
||||
code_execution: true
|
||||
web_retrieval: true
|
||||
literature: true
|
||||
omics: limited
|
||||
wet_lab: false
|
||||
autonomous_experiment: limited
|
||||
human_in_loop: true
|
||||
open_source: true
|
||||
|
||||
autoba:
|
||||
agent_profile:
|
||||
year: 2024
|
||||
domains: [bioinformatics, omics, scientific-workflow]
|
||||
architecture: single-agent
|
||||
tool_use: true
|
||||
code_execution: true
|
||||
web_retrieval: limited
|
||||
literature: limited
|
||||
omics: true
|
||||
wet_lab: false
|
||||
autonomous_experiment: true
|
||||
human_in_loop: true
|
||||
open_source: true
|
||||
|
||||
genomas:
|
||||
agent_profile:
|
||||
year: 2025
|
||||
domains: [bioinformatics, gene-expression, scientific-workflow]
|
||||
architecture: multi-agent
|
||||
tool_use: true
|
||||
code_execution: true
|
||||
web_retrieval: limited
|
||||
literature: true
|
||||
omics: true
|
||||
wet_lab: false
|
||||
autonomous_experiment: true
|
||||
human_in_loop: true
|
||||
open_source: true
|
||||
|
||||
bia:
|
||||
agent_profile:
|
||||
domains: [bioinformatics, genomics, literature]
|
||||
architecture: single-agent
|
||||
tool_use: true
|
||||
code_execution: true
|
||||
web_retrieval: true
|
||||
literature: true
|
||||
omics: true
|
||||
wet_lab: false
|
||||
autonomous_experiment: limited
|
||||
human_in_loop: true
|
||||
open_source: true
|
||||
|
||||
bioagents:
|
||||
agent_profile:
|
||||
year: 2025
|
||||
domains: [bioinformatics, genomics, scientific-workflow]
|
||||
architecture: multi-agent
|
||||
tool_use: true
|
||||
code_execution: limited
|
||||
web_retrieval: limited
|
||||
literature: limited
|
||||
omics: true
|
||||
wet_lab: false
|
||||
autonomous_experiment: limited
|
||||
human_in_loop: true
|
||||
open_source: true
|
||||
|
||||
genomi:
|
||||
agent_profile:
|
||||
year: 2026
|
||||
domains: [genomics, precision-medicine, evidence-synthesis]
|
||||
architecture: agent-ecosystem
|
||||
tool_use: true
|
||||
code_execution: limited
|
||||
web_retrieval: limited
|
||||
literature: true
|
||||
omics: limited
|
||||
wet_lab: false
|
||||
autonomous_experiment: false
|
||||
human_in_loop: true
|
||||
open_source: true
|
||||
+46
-4
@@ -2,9 +2,9 @@
|
||||
title: "Provenance-backed single-cell and biomedical benchmark enrichment batch."
|
||||
task: ""
|
||||
lineage_type: import
|
||||
upstream_source: https://github.com/inoue0426/awesome-computational-biology/blob/7a064bf0/data/enrichment.benchmark-v2.yml
|
||||
upstream_sha: 7a064bf0
|
||||
imported_at: 2026-08-08
|
||||
upstream_source: https://github.com/inoue0426/awesome-computational-biology/blob/4ed7cfef/data/enrichment.benchmark-v2.yml
|
||||
upstream_sha: 4ed7cfef
|
||||
imported_at: 2026-10-26
|
||||
prompt_class: catalogue
|
||||
upstream_changes: accepted
|
||||
author: upstream
|
||||
@@ -39,13 +39,55 @@ resources:
|
||||
last_checked: 2026-08-08
|
||||
metadata_sources:
|
||||
- https://lincsproject.org/LINCS/tools/workflows/find-the-best-place-to-obtain-the-lincs-l1000-data
|
||||
dataset_profile:
|
||||
year: 2017
|
||||
readout: l1000
|
||||
gene_panel: "978 landmark genes"
|
||||
time: true
|
||||
view_scope: full-resource
|
||||
species: [human]
|
||||
sample_type: cell-line
|
||||
biological_context: perturbation-screen
|
||||
perturbation_type: [chemical, genetic]
|
||||
genetic_modes: [mixed]
|
||||
paired: false
|
||||
pre_post: false
|
||||
longitudinal: false
|
||||
drug_identity: true
|
||||
dose: true
|
||||
smiles: partial
|
||||
clinical_outcome: false
|
||||
n_samples: "large-scale perturbational profiles"
|
||||
n_cells: null
|
||||
access: open
|
||||
|
||||
prism:
|
||||
entities: [cell, drug]
|
||||
tasks: [drug-response-prediction]
|
||||
last_checked: 2026-08-08
|
||||
last_checked: 2026-10-02
|
||||
metadata_sources:
|
||||
- https://depmap.org/portal/prism/
|
||||
dataset_profile:
|
||||
year: 2020
|
||||
readout: viability
|
||||
n_compounds: ">4,500"
|
||||
n_contexts: ">900 cell lines"
|
||||
time: false
|
||||
view_scope: full-resource
|
||||
species: [human]
|
||||
sample_type: cell-line
|
||||
biological_context: cancer
|
||||
perturbation_type: [chemical]
|
||||
paired: true
|
||||
pre_post: false
|
||||
longitudinal: false
|
||||
drug_identity: true
|
||||
dose: true
|
||||
smiles: partial
|
||||
clinical_outcome: false
|
||||
n_samples: "PRISM pooled viability screens"
|
||||
n_cells: null
|
||||
access: open
|
||||
|
||||
pharmgkb:
|
||||
entities: [drug, gene, phenotype, variant]
|
||||
|
||||
+125
@@ -0,0 +1,125 @@
|
||||
---
|
||||
title: "Provenance-backed cancer and pharmacogenomics database enrichment batch."
|
||||
task: ""
|
||||
lineage_type: import
|
||||
upstream_source: https://github.com/inoue0426/awesome-computational-biology/blob/4ed7cfef/data/enrichment.cancer-databases-v1.yml
|
||||
upstream_sha: 4ed7cfef
|
||||
imported_at: 2026-10-26
|
||||
prompt_class: catalogue
|
||||
upstream_changes: accepted
|
||||
author: upstream
|
||||
validated: false
|
||||
---
|
||||
|
||||
# Provenance-backed cancer and pharmacogenomics database enrichment batch.
|
||||
resources:
|
||||
cancer_cell_line_encyclopedia:
|
||||
entities: [cell, gene, disease, drug]
|
||||
modalities: [genomics, transcriptomics]
|
||||
documentation: https://sites.broadinstitute.org/ccle/
|
||||
last_checked: 2026-08-08
|
||||
metadata_sources:
|
||||
- https://sites.broadinstitute.org/ccle/
|
||||
|
||||
catalogue_of_somatic_mutations_in_cancer_cosmic:
|
||||
entities: [disease, gene, variant]
|
||||
modalities: [genomics]
|
||||
documentation: https://cancer.sanger.ac.uk/cosmic
|
||||
last_checked: 2026-08-08
|
||||
metadata_sources:
|
||||
- https://cancer.sanger.ac.uk/cosmic
|
||||
|
||||
cbioportal:
|
||||
entities: [disease, gene, variant]
|
||||
modalities: [genomics, clinical]
|
||||
github: https://github.com/cBioPortal/cbioportal
|
||||
documentation: https://www.cbioportal.org/
|
||||
last_checked: 2026-08-08
|
||||
metadata_sources:
|
||||
- https://www.cbioportal.org/
|
||||
- https://github.com/cBioPortal/cbioportal
|
||||
|
||||
dependency_map_depmap:
|
||||
entities: [cell, gene, disease, drug]
|
||||
modalities: [genomics]
|
||||
documentation: https://depmap.org/portal/
|
||||
last_checked: 2026-08-08
|
||||
metadata_sources:
|
||||
- https://depmap.org/portal/
|
||||
|
||||
dgidb:
|
||||
entities: [drug, gene]
|
||||
modalities: [knowledge-graph]
|
||||
documentation: https://www.dgidb.org/
|
||||
last_checked: 2026-08-08
|
||||
metadata_sources:
|
||||
- https://www.dgidb.org/
|
||||
|
||||
drug_mechanism_database_drugmechdb:
|
||||
entities: [drug, disease, gene, pathway]
|
||||
modalities: [knowledge-graph]
|
||||
github: https://github.com/SuLab/DrugMechDB
|
||||
last_checked: 2026-08-08
|
||||
metadata_sources:
|
||||
- https://github.com/SuLab/DrugMechDB
|
||||
|
||||
drug_repurposing_hub:
|
||||
entities: [drug, protein, disease]
|
||||
modalities: [chemical-structure]
|
||||
documentation: https://repo-hub.broadinstitute.org/repurposing
|
||||
last_checked: 2026-08-08
|
||||
metadata_sources:
|
||||
- https://repo-hub.broadinstitute.org/repurposing
|
||||
|
||||
drugcentral:
|
||||
entities: [drug, protein, disease]
|
||||
modalities: [chemical-structure]
|
||||
documentation: https://drugcentral.org/
|
||||
last_checked: 2026-08-08
|
||||
metadata_sources:
|
||||
- https://drugcentral.org/
|
||||
|
||||
drugtargetcommons:
|
||||
entities: [drug, protein]
|
||||
modalities: [chemical-structure]
|
||||
documentation: https://drugtargetcommons.fimm.fi/
|
||||
last_checked: 2026-08-08
|
||||
metadata_sources:
|
||||
- https://drugtargetcommons.fimm.fi/
|
||||
|
||||
comparative_toxicogenomics_database:
|
||||
entities: [compound, gene, disease]
|
||||
modalities: [knowledge-graph]
|
||||
documentation: https://ctdbase.org/
|
||||
last_checked: 2026-08-08
|
||||
metadata_sources:
|
||||
- https://ctdbase.org/
|
||||
|
||||
the_cancer_genome_atlas_tcga:
|
||||
entities: [disease, gene]
|
||||
modalities: [clinical, genomics]
|
||||
last_checked: 2026-10-02
|
||||
metadata_sources:
|
||||
- https://www.cancer.gov/ccg/research/genome-sequencing/tcga
|
||||
dataset_profile:
|
||||
year: 2018
|
||||
readout: multi-omics
|
||||
n_profiles: ">11,000 patients"
|
||||
n_contexts: 33
|
||||
gene_panel: "transcriptome-wide plus multi-omics"
|
||||
time: false
|
||||
view_scope: full-resource
|
||||
species: [human]
|
||||
sample_type: patient
|
||||
biological_context: cancer
|
||||
perturbation_type: []
|
||||
paired: false
|
||||
pre_post: false
|
||||
longitudinal: false
|
||||
drug_identity: limited
|
||||
dose: false
|
||||
smiles: false
|
||||
clinical_outcome: true
|
||||
n_samples: ">11,000 patients across 33 cancer types"
|
||||
n_cells: null
|
||||
access: mixed
|
||||
+785
@@ -0,0 +1,785 @@
|
||||
---
|
||||
title: "Foundation Model Explorer v1 metadata."
|
||||
task: ""
|
||||
lineage_type: import
|
||||
upstream_source: https://github.com/inoue0426/awesome-computational-biology/blob/4ed7cfef/data/enrichment.foundation-explorer-v1.yml
|
||||
upstream_sha: 4ed7cfef
|
||||
imported_at: 2026-10-26
|
||||
prompt_class: unknown
|
||||
upstream_changes: accepted
|
||||
author: upstream
|
||||
validated: false
|
||||
---
|
||||
|
||||
# Foundation Model Explorer v1 metadata.
|
||||
# Fine-grained modalities intentionally distinguish assay/data types for navigation.
|
||||
resources:
|
||||
scfoundation:
|
||||
foundation_profile:
|
||||
year: 2024
|
||||
modalities: [scrna]
|
||||
params: "100M"
|
||||
params_millions: 100
|
||||
pretraining_scale: ">50M human single-cell transcriptomes"
|
||||
species: [human]
|
||||
zero_shot: limited
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: true
|
||||
perturbation: limited
|
||||
spatial: false
|
||||
|
||||
scgpt:
|
||||
foundation_profile:
|
||||
year: 2024
|
||||
modalities: [scrna, multi-omics]
|
||||
pretraining_scale: ">33M single-cell profiles"
|
||||
species: [human]
|
||||
zero_shot: limited
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: true
|
||||
perturbation: true
|
||||
spatial: limited
|
||||
|
||||
geneformer:
|
||||
foundation_profile:
|
||||
year: 2024
|
||||
modalities: [scrna]
|
||||
params: "10M / 104M / 316M"
|
||||
params_millions: 316
|
||||
pretraining_scale: "~104M human single-cell transcriptomes in V2; original corpus ~30M"
|
||||
species: [human]
|
||||
zero_shot: true
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: true
|
||||
perturbation: true
|
||||
spatial: false
|
||||
|
||||
bulkformer:
|
||||
foundation_profile:
|
||||
year: 2025
|
||||
modalities: [bulk-rna]
|
||||
pretraining_scale: "bulk RNA-seq compendium"
|
||||
species: [human]
|
||||
zero_shot: limited
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: true
|
||||
perturbation: false
|
||||
spatial: false
|
||||
|
||||
scbert:
|
||||
foundation_profile:
|
||||
year: 2022
|
||||
modalities: [scrna]
|
||||
pretraining_scale: "large-scale scRNA-seq corpus"
|
||||
species: [human]
|
||||
zero_shot: limited
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: true
|
||||
perturbation: false
|
||||
spatial: false
|
||||
|
||||
cellplm:
|
||||
foundation_profile:
|
||||
year: 2023
|
||||
modalities: [scrna]
|
||||
pretraining_scale: "multi-dataset single-cell pretraining"
|
||||
species: [human]
|
||||
zero_shot: limited
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: true
|
||||
perturbation: limited
|
||||
spatial: false
|
||||
|
||||
uce:
|
||||
foundation_profile:
|
||||
year: 2026
|
||||
modalities: [scrna]
|
||||
params: ">650M"
|
||||
params_millions: 650
|
||||
pretraining_scale: ">36M cells across >300 datasets"
|
||||
species: [multi-species]
|
||||
zero_shot: true
|
||||
finetunable: limited
|
||||
weights: true
|
||||
code: true
|
||||
perturbation: false
|
||||
spatial: false
|
||||
|
||||
saturn:
|
||||
foundation_profile:
|
||||
year: 2024
|
||||
modalities: [scrna, protein]
|
||||
pretraining_scale: "cross-species single-cell atlases with protein-language-model embeddings"
|
||||
species: [multi-species]
|
||||
zero_shot: limited
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: true
|
||||
perturbation: false
|
||||
spatial: false
|
||||
|
||||
cancerfoundation:
|
||||
foundation_profile:
|
||||
year: 2025
|
||||
modalities: [scrna]
|
||||
pretraining_scale: "curated malignant-cell single-cell corpus"
|
||||
species: [human]
|
||||
zero_shot: limited
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: true
|
||||
perturbation: limited
|
||||
spatial: false
|
||||
|
||||
cellfm:
|
||||
foundation_profile:
|
||||
year: 2025
|
||||
modalities: [scrna]
|
||||
params: "800M"
|
||||
params_millions: 800
|
||||
pretraining_scale: "100M human cells"
|
||||
species: [human]
|
||||
zero_shot: limited
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: true
|
||||
perturbation: true
|
||||
spatial: false
|
||||
|
||||
scprint:
|
||||
foundation_profile:
|
||||
year: 2025
|
||||
modalities: [scrna]
|
||||
pretraining_scale: "large multi-dataset single-cell corpus"
|
||||
species: [human]
|
||||
zero_shot: limited
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: true
|
||||
perturbation: limited
|
||||
spatial: false
|
||||
|
||||
scprint_2:
|
||||
foundation_profile:
|
||||
year: 2026
|
||||
modalities: [scrna]
|
||||
pretraining_scale: "350M+ cells; 22K+ datasets; 16 species"
|
||||
species: [multi-species]
|
||||
zero_shot: true
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: true
|
||||
perturbation: limited
|
||||
spatial: false
|
||||
|
||||
nicheformer:
|
||||
foundation_profile:
|
||||
year: 2025
|
||||
modalities: [scrna, spatial]
|
||||
params: "49.3M"
|
||||
params_millions: 49.3
|
||||
pretraining_scale: "SpatialCorpus-110M"
|
||||
species: [human, mouse]
|
||||
zero_shot: true
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: true
|
||||
perturbation: false
|
||||
spatial: true
|
||||
|
||||
scgpt_spatial:
|
||||
foundation_profile:
|
||||
year: 2025
|
||||
modalities: [scrna, spatial, multi-omics]
|
||||
pretraining_scale: "continued pretraining from scGPT with spatial transcriptomics"
|
||||
species: [human, mouse]
|
||||
zero_shot: limited
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: true
|
||||
perturbation: false
|
||||
spatial: true
|
||||
|
||||
scmulan:
|
||||
foundation_profile:
|
||||
year: 2024
|
||||
modalities: [scrna, atac, proteomics, multi-omics]
|
||||
pretraining_scale: "~10M cells across transcriptomics, epigenomics, and proteomics"
|
||||
species: [human, mouse]
|
||||
zero_shot: limited
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: true
|
||||
perturbation: false
|
||||
spatial: false
|
||||
|
||||
genecompass:
|
||||
foundation_profile:
|
||||
year: 2024
|
||||
modalities: [scrna, dna, multi-omics]
|
||||
pretraining_scale: "120M+ cells across multiple species"
|
||||
species: [multi-species]
|
||||
zero_shot: limited
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: true
|
||||
perturbation: limited
|
||||
spatial: false
|
||||
|
||||
titan:
|
||||
foundation_profile:
|
||||
year: 2025
|
||||
modalities: [pathology]
|
||||
pretraining_scale: "whole-slide pathology with multimodal image-language supervision"
|
||||
species: [human]
|
||||
zero_shot: true
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: true
|
||||
perturbation: false
|
||||
spatial: false
|
||||
|
||||
virchow2:
|
||||
foundation_profile:
|
||||
year: 2024
|
||||
modalities: [pathology]
|
||||
params: "632M"
|
||||
params_millions: 632
|
||||
pretraining_scale: "3.1M whole-slide images"
|
||||
species: [human]
|
||||
zero_shot: limited
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: limited
|
||||
perturbation: false
|
||||
spatial: false
|
||||
|
||||
h_optimus_0:
|
||||
foundation_profile:
|
||||
year: 2024
|
||||
modalities: [pathology]
|
||||
params: "1.1B"
|
||||
params_millions: 1100
|
||||
pretraining_scale: "large multi-center histopathology corpus"
|
||||
species: [human]
|
||||
zero_shot: limited
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: limited
|
||||
perturbation: false
|
||||
spatial: false
|
||||
|
||||
h_optimus_1:
|
||||
foundation_profile:
|
||||
year: 2025
|
||||
modalities: [pathology]
|
||||
params: "1.1B"
|
||||
params_millions: 1100
|
||||
pretraining_scale: ">1M slides; >800K patients"
|
||||
species: [human]
|
||||
zero_shot: limited
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: limited
|
||||
perturbation: false
|
||||
spatial: false
|
||||
|
||||
uni2_h:
|
||||
foundation_profile:
|
||||
year: 2025
|
||||
modalities: [pathology]
|
||||
params: "~1B"
|
||||
params_millions: 1000
|
||||
pretraining_scale: "large-scale histopathology pretraining"
|
||||
species: [human]
|
||||
zero_shot: limited
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: limited
|
||||
perturbation: false
|
||||
spatial: false
|
||||
|
||||
phikon_v2:
|
||||
foundation_profile:
|
||||
year: 2025
|
||||
modalities: [pathology]
|
||||
pretraining_scale: "large-scale histopathology pretraining"
|
||||
species: [human]
|
||||
zero_shot: limited
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: limited
|
||||
perturbation: false
|
||||
spatial: false
|
||||
|
||||
genbio_pathfm:
|
||||
foundation_profile:
|
||||
year: 2026
|
||||
modalities: [pathology]
|
||||
params: "1.1B"
|
||||
params_millions: 1100
|
||||
pretraining_scale: "public histopathology corpus with morphology-aware curation"
|
||||
species: [human]
|
||||
zero_shot: limited
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: true
|
||||
perturbation: false
|
||||
spatial: false
|
||||
|
||||
uni_mol:
|
||||
foundation_profile:
|
||||
year: 2023
|
||||
modalities: [chemical, protein]
|
||||
pretraining_scale: "large-scale 3D molecular and pocket pretraining"
|
||||
species: [multi-species]
|
||||
zero_shot: limited
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: true
|
||||
perturbation: false
|
||||
spatial: false
|
||||
|
||||
uni_mol2:
|
||||
foundation_profile:
|
||||
year: 2024
|
||||
modalities: [chemical]
|
||||
params: "up to 1.1B"
|
||||
params_millions: 1100
|
||||
pretraining_scale: "800M molecular conformations"
|
||||
species: []
|
||||
zero_shot: limited
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: true
|
||||
perturbation: false
|
||||
spatial: false
|
||||
|
||||
chemfm:
|
||||
foundation_profile:
|
||||
year: 2024
|
||||
modalities: [chemical]
|
||||
params: "1B / 3B"
|
||||
params_millions: 3000
|
||||
pretraining_scale: "178M molecules"
|
||||
species: []
|
||||
zero_shot: limited
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: true
|
||||
perturbation: false
|
||||
spatial: false
|
||||
|
||||
esm_cambrian_esm_c:
|
||||
foundation_profile:
|
||||
year: 2024
|
||||
modalities: [protein]
|
||||
params: "300M / 600M / 6B"
|
||||
params_millions: 6000
|
||||
pretraining_scale: "evolutionary-scale protein sequence corpus"
|
||||
species: [multi-species]
|
||||
zero_shot: true
|
||||
finetunable: true
|
||||
weights: limited
|
||||
code: true
|
||||
perturbation: false
|
||||
spatial: false
|
||||
|
||||
esm3:
|
||||
foundation_profile:
|
||||
year: 2024
|
||||
modalities: [protein]
|
||||
params: "1.4B / 7B / 98B"
|
||||
params_millions: 98000
|
||||
pretraining_scale: "multimodal protein sequence, structure, and function corpus"
|
||||
species: [multi-species]
|
||||
zero_shot: true
|
||||
finetunable: limited
|
||||
weights: limited
|
||||
code: true
|
||||
perturbation: false
|
||||
spatial: false
|
||||
|
||||
boltz_2:
|
||||
foundation_profile:
|
||||
year: 2025
|
||||
modalities: [protein, chemical]
|
||||
pretraining_scale: "biomolecular complex structure and affinity data"
|
||||
species: [multi-species]
|
||||
zero_shot: true
|
||||
finetunable: limited
|
||||
weights: true
|
||||
code: true
|
||||
perturbation: false
|
||||
spatial: false
|
||||
|
||||
protenix:
|
||||
foundation_profile:
|
||||
year: 2025
|
||||
modalities: [protein, chemical]
|
||||
pretraining_scale: "biomolecular structure pretraining"
|
||||
species: [multi-species]
|
||||
zero_shot: true
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: true
|
||||
perturbation: false
|
||||
spatial: false
|
||||
|
||||
rna_fm:
|
||||
foundation_profile:
|
||||
year: 2022
|
||||
modalities: [rna]
|
||||
params: "99M"
|
||||
params_millions: 99
|
||||
pretraining_scale: "23.7M non-coding RNA sequences"
|
||||
species: [multi-species]
|
||||
zero_shot: true
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: true
|
||||
perturbation: false
|
||||
spatial: false
|
||||
|
||||
rinalmo:
|
||||
foundation_profile:
|
||||
year: 2025
|
||||
modalities: [rna]
|
||||
params: "33.5M / 148M / 650M"
|
||||
params_millions: 650
|
||||
pretraining_scale: "36M non-coding RNA sequences"
|
||||
species: [multi-species]
|
||||
zero_shot: true
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: true
|
||||
perturbation: false
|
||||
spatial: false
|
||||
|
||||
evo_2:
|
||||
foundation_profile:
|
||||
year: 2026
|
||||
modalities: [dna]
|
||||
params: "1B / 7B / 40B"
|
||||
params_millions: 40000
|
||||
pretraining_scale: "9T DNA base pairs"
|
||||
species: [multi-species]
|
||||
zero_shot: true
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: true
|
||||
perturbation: false
|
||||
spatial: false
|
||||
|
||||
alphagenome:
|
||||
foundation_profile:
|
||||
year: 2025
|
||||
modalities: [dna]
|
||||
pretraining_scale: "long-context regulatory genomics corpus"
|
||||
species: [human, mouse]
|
||||
zero_shot: true
|
||||
finetunable: unknown
|
||||
weights: no
|
||||
code: limited
|
||||
perturbation: false
|
||||
spatial: false
|
||||
|
||||
moderngena:
|
||||
foundation_profile:
|
||||
year: 2026
|
||||
modalities: [dna]
|
||||
pretraining_scale: "hundreds of vertebrate genome assemblies"
|
||||
species: [multi-species]
|
||||
zero_shot: limited
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: true
|
||||
perturbation: false
|
||||
spatial: false
|
||||
|
||||
nucleotide_transformer:
|
||||
foundation_profile:
|
||||
year: 2025
|
||||
modalities: [dna]
|
||||
params: "50M – 2.5B"
|
||||
params_millions: 2500
|
||||
pretraining_scale: "3,202 human genomes and up to 850 species"
|
||||
species: [multi-species]
|
||||
zero_shot: true
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: true
|
||||
perturbation: false
|
||||
spatial: false
|
||||
|
||||
dnabert_2:
|
||||
foundation_profile:
|
||||
year: 2023
|
||||
modalities: [dna]
|
||||
params: "117M"
|
||||
params_millions: 117
|
||||
pretraining_scale: "multi-species GenBank genome corpus"
|
||||
species: [multi-species]
|
||||
zero_shot: limited
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: true
|
||||
perturbation: false
|
||||
spatial: false
|
||||
|
||||
caduceus:
|
||||
foundation_profile:
|
||||
year: 2024
|
||||
modalities: [dna]
|
||||
pretraining_scale: "long-range genomic sequence pretraining"
|
||||
species: [human]
|
||||
zero_shot: limited
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: true
|
||||
perturbation: false
|
||||
spatial: false
|
||||
|
||||
hyenadna:
|
||||
foundation_profile:
|
||||
year: 2023
|
||||
modalities: [dna]
|
||||
pretraining_scale: "long-context human genome sequence"
|
||||
species: [human]
|
||||
zero_shot: limited
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: true
|
||||
perturbation: false
|
||||
spatial: false
|
||||
|
||||
gpn_genomic_pre_trained_network:
|
||||
foundation_profile:
|
||||
year: 2023
|
||||
modalities: [dna]
|
||||
pretraining_scale: "genomic sequence pretraining for variant-effect prediction"
|
||||
species: [multi-species]
|
||||
zero_shot: true
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: true
|
||||
perturbation: false
|
||||
spatial: false
|
||||
|
||||
methylgpt:
|
||||
foundation_profile:
|
||||
year: 2024
|
||||
modalities: [methylation]
|
||||
params: "3M / 7M / 15M"
|
||||
params_millions: 15
|
||||
pretraining_scale: "154,063 human methylomes after QC; 5,281 datasets; 49,156 CpG sites"
|
||||
species: [human]
|
||||
zero_shot: limited
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: true
|
||||
perturbation: false
|
||||
spatial: false
|
||||
|
||||
cpgpt:
|
||||
foundation_profile:
|
||||
year: 2025
|
||||
modalities: [methylation]
|
||||
pretraining_scale: "150K+ methylation samples across >2,000 datasets"
|
||||
species: [human]
|
||||
zero_shot: true
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: true
|
||||
perturbation: false
|
||||
spatial: false
|
||||
|
||||
mutationprojector:
|
||||
foundation_profile:
|
||||
year: 2026
|
||||
modalities: [mutation, copy-number]
|
||||
pretraining_scale: ">30K tumors with somatic genomic alterations including copy-number changes"
|
||||
species: [human]
|
||||
zero_shot: limited
|
||||
finetunable: unknown
|
||||
weights: unknown
|
||||
code: unknown
|
||||
perturbation: false
|
||||
spatial: false
|
||||
|
||||
casanovo_foundation:
|
||||
foundation_profile:
|
||||
year: 2025
|
||||
modalities: [proteomics]
|
||||
pretraining_scale: "30M labeled tandem mass spectra"
|
||||
species: [human]
|
||||
zero_shot: limited
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: true
|
||||
perturbation: false
|
||||
spatial: false
|
||||
|
||||
tessera:
|
||||
foundation_profile:
|
||||
year: 2026
|
||||
modalities: [mutation, copy-number]
|
||||
pretraining_scale: "TCGA pan-cancer somatic SNVs and copy-number segments"
|
||||
species: [human]
|
||||
zero_shot: limited
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: true
|
||||
perturbation: false
|
||||
spatial: false
|
||||
|
||||
epiagent:
|
||||
foundation_profile:
|
||||
year: 2025
|
||||
modalities: [atac]
|
||||
pretraining_scale: ">5.4M scATAC-seq cells across 37 tissues or cell lines"
|
||||
species: [human]
|
||||
zero_shot: limited
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: true
|
||||
perturbation: true
|
||||
spatial: false
|
||||
|
||||
scarf:
|
||||
foundation_profile:
|
||||
year: 2025
|
||||
modalities: [scrna, atac, multi-omics]
|
||||
pretraining_scale: ">2.7M paired and unpaired single cells across tissues and species"
|
||||
species: [multi-species]
|
||||
zero_shot: limited
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: true
|
||||
perturbation: limited
|
||||
spatial: false
|
||||
|
||||
scdnam_gpt:
|
||||
foundation_profile:
|
||||
year: 2025
|
||||
modalities: [methylation]
|
||||
pretraining_scale: ">1M single-cell methylomes from human and mouse tissues"
|
||||
species: [human, mouse]
|
||||
zero_shot: true
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: true
|
||||
perturbation: false
|
||||
spatial: false
|
||||
|
||||
epifoundation:
|
||||
foundation_profile:
|
||||
year: 2025
|
||||
modalities: [atac]
|
||||
pretraining_scale: "large-scale scATAC-seq pretraining with peak-to-gene alignment"
|
||||
species: [human]
|
||||
zero_shot: limited
|
||||
finetunable: true
|
||||
weights: limited
|
||||
code: limited
|
||||
perturbation: false
|
||||
spatial: false
|
||||
|
||||
chromfound:
|
||||
foundation_profile:
|
||||
year: 2025
|
||||
modalities: [atac]
|
||||
pretraining_scale: "1.97M scATAC-seq cells; 30 tissues; 6 disease contexts"
|
||||
species: [human]
|
||||
zero_shot: true
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: true
|
||||
perturbation: false
|
||||
spatial: false
|
||||
|
||||
atacformer:
|
||||
foundation_profile:
|
||||
year: 2025
|
||||
modalities: [atac]
|
||||
pretraining_scale: "large atlas of scATAC-seq experiments"
|
||||
species: [human]
|
||||
zero_shot: limited
|
||||
finetunable: true
|
||||
weights: unknown
|
||||
code: unknown
|
||||
perturbation: false
|
||||
spatial: false
|
||||
|
||||
clm_x:
|
||||
foundation_profile:
|
||||
year: 2026
|
||||
modalities: [scrna, atac, multi-omics]
|
||||
pretraining_scale: "million-scale RNA-only, ATAC-only, and paired RNA-ATAC data"
|
||||
species: [human]
|
||||
zero_shot: limited
|
||||
finetunable: true
|
||||
weights: unknown
|
||||
code: unknown
|
||||
perturbation: true
|
||||
spatial: false
|
||||
|
||||
captain:
|
||||
foundation_profile:
|
||||
year: 2026
|
||||
modalities: [scrna, proteomics, multi-omics]
|
||||
pretraining_scale: "co-assayed single-cell RNA and protein data"
|
||||
species: [human]
|
||||
zero_shot: limited
|
||||
finetunable: true
|
||||
weights: unknown
|
||||
code: unknown
|
||||
perturbation: false
|
||||
spatial: false
|
||||
|
||||
hicfoundation:
|
||||
foundation_profile:
|
||||
year: 2026
|
||||
modalities: [hic]
|
||||
pretraining_scale: "hundreds of Hi-C assays; 118M contact-matrix submatrices"
|
||||
species: [multi-species]
|
||||
zero_shot: limited
|
||||
finetunable: true
|
||||
weights: unknown
|
||||
code: unknown
|
||||
perturbation: false
|
||||
spatial: false
|
||||
|
||||
omicsfm:
|
||||
foundation_profile:
|
||||
year: 2026
|
||||
modalities: [proteomics, bulk-rna, scrna]
|
||||
params: "4.9M"
|
||||
params_millions: 4.9
|
||||
pretraining_scale: "48,837 proteomics profiles; 680,216 bulk RNA profiles; 4.55M single cells"
|
||||
species: [human]
|
||||
zero_shot: limited
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: true
|
||||
perturbation: false
|
||||
spatial: false
|
||||
|
||||
virtues:
|
||||
foundation_profile:
|
||||
year: 2026
|
||||
modalities: [proteomics, spatial]
|
||||
pretraining_scale: "31-32 harmonized spatial-proteomics datasets across technologies"
|
||||
species: [human]
|
||||
zero_shot: true
|
||||
finetunable: true
|
||||
weights: true
|
||||
code: true
|
||||
perturbation: false
|
||||
spatial: true
|
||||
+232
@@ -0,0 +1,232 @@
|
||||
---
|
||||
title: "Provenance-backed foundation model enrichment batch 3."
|
||||
task: ""
|
||||
lineage_type: import
|
||||
upstream_source: https://github.com/inoue0426/awesome-computational-biology/blob/4ed7cfef/data/enrichment.foundation-models-v3.yml
|
||||
upstream_sha: 4ed7cfef
|
||||
imported_at: 2026-10-26
|
||||
prompt_class: catalogue
|
||||
upstream_changes: accepted
|
||||
author: upstream
|
||||
validated: false
|
||||
---
|
||||
|
||||
# Provenance-backed foundation model enrichment batch 3.
|
||||
resources:
|
||||
cellfm:
|
||||
entities: [cell, gene]
|
||||
methods: [self-supervised-learning, transformer]
|
||||
modalities: [single-cell-rna-seq, transcriptomics]
|
||||
tasks: [cell-type-annotation, foundation-model-pretraining, perturbation-prediction, representation-learning]
|
||||
year: 2025
|
||||
github: https://github.com/biomed-AI/CellFM
|
||||
paper: https://doi.org/10.1038/s41467-025-59926-5
|
||||
last_checked: 2026-10-02
|
||||
metadata_sources:
|
||||
- https://github.com/biomed-AI/CellFM
|
||||
- https://doi.org/10.1038/s41467-025-59926-5
|
||||
|
||||
scprint_2:
|
||||
entities: [cell, gene]
|
||||
methods: [self-supervised-learning, transformer]
|
||||
modalities: [single-cell-rna-seq, transcriptomics]
|
||||
tasks: [batch-correction, cell-type-annotation, foundation-model-pretraining, gene-regulatory-network-inference, imputation, representation-learning]
|
||||
year: 2026
|
||||
github: https://github.com/cantinilab/scPRINT-2
|
||||
last_checked: 2026-10-02
|
||||
metadata_sources:
|
||||
- https://github.com/cantinilab/scPRINT-2
|
||||
|
||||
titan:
|
||||
entities: [disease, tissue]
|
||||
methods: [contrastive-learning, self-supervised-learning, transformer]
|
||||
modalities: [histopathology, imaging]
|
||||
tasks: [classification, foundation-model-pretraining, representation-learning]
|
||||
year: 2025
|
||||
github: https://github.com/mahmoodlab/TITAN
|
||||
last_checked: 2026-10-02
|
||||
metadata_sources:
|
||||
- https://github.com/mahmoodlab/TITAN
|
||||
|
||||
virchow2:
|
||||
entities: [disease, tissue]
|
||||
methods: [self-supervised-learning, transformer]
|
||||
modalities: [histopathology, imaging]
|
||||
tasks: [classification, foundation-model-pretraining, representation-learning]
|
||||
year: 2024
|
||||
documentation: https://huggingface.co/paige-ai/Virchow2
|
||||
last_checked: 2026-10-02
|
||||
metadata_sources:
|
||||
- https://huggingface.co/paige-ai/Virchow2
|
||||
|
||||
h_optimus_0:
|
||||
entities: [disease, tissue]
|
||||
methods: [self-supervised-learning, transformer]
|
||||
modalities: [histopathology, imaging]
|
||||
tasks: [classification, foundation-model-pretraining, representation-learning]
|
||||
year: 2024
|
||||
documentation: https://huggingface.co/bioptimus/H-optimus-0
|
||||
last_checked: 2026-10-02
|
||||
metadata_sources:
|
||||
- https://huggingface.co/bioptimus/H-optimus-0
|
||||
|
||||
h_optimus_1:
|
||||
entities: [disease, tissue]
|
||||
methods: [self-supervised-learning, transformer]
|
||||
modalities: [histopathology, imaging]
|
||||
tasks: [classification, foundation-model-pretraining, representation-learning]
|
||||
year: 2025
|
||||
documentation: https://huggingface.co/bioptimus/H-optimus-1
|
||||
last_checked: 2026-10-02
|
||||
metadata_sources:
|
||||
- https://huggingface.co/bioptimus/H-optimus-1
|
||||
|
||||
uni2_h:
|
||||
entities: [disease, tissue]
|
||||
methods: [self-supervised-learning, transformer]
|
||||
modalities: [histopathology, imaging]
|
||||
tasks: [classification, foundation-model-pretraining, representation-learning]
|
||||
year: 2025
|
||||
documentation: https://huggingface.co/MahmoodLab/UNI2-h
|
||||
last_checked: 2026-10-02
|
||||
metadata_sources:
|
||||
- https://huggingface.co/MahmoodLab/UNI2-h
|
||||
|
||||
phikon_v2:
|
||||
entities: [disease, tissue]
|
||||
methods: [self-supervised-learning, transformer]
|
||||
modalities: [histopathology, imaging]
|
||||
tasks: [classification, foundation-model-pretraining, representation-learning]
|
||||
year: 2025
|
||||
documentation: https://huggingface.co/owkin/phikon-v2
|
||||
last_checked: 2026-10-02
|
||||
metadata_sources:
|
||||
- https://huggingface.co/owkin/phikon-v2
|
||||
|
||||
genbio_pathfm:
|
||||
entities: [disease, tissue]
|
||||
methods: [self-supervised-learning, transformer]
|
||||
modalities: [histopathology, imaging]
|
||||
tasks: [classification, foundation-model-pretraining, representation-learning]
|
||||
year: 2026
|
||||
github: https://github.com/genbio-ai/genbio-pathfm
|
||||
paper: https://www.biorxiv.org/content/10.64898/2026.03.17.712534v1
|
||||
last_checked: 2026-10-02
|
||||
metadata_sources:
|
||||
- https://github.com/genbio-ai/genbio-pathfm
|
||||
- https://www.biorxiv.org/content/10.64898/2026.03.17.712534v1
|
||||
|
||||
uni_mol2:
|
||||
entities: [molecule]
|
||||
methods: [self-supervised-learning, transformer]
|
||||
modalities: [chemical-structure, molecular-structure]
|
||||
tasks: [foundation-model-pretraining, representation-learning]
|
||||
year: 2024
|
||||
github: https://github.com/deepmodeling/Uni-Mol
|
||||
last_checked: 2026-10-02
|
||||
metadata_sources:
|
||||
- https://github.com/deepmodeling/Uni-Mol
|
||||
|
||||
chemfm:
|
||||
entities: [molecule]
|
||||
methods: [generative-model, language-model, transformer]
|
||||
modalities: [chemical-structure]
|
||||
tasks: [foundation-model-pretraining, molecular-generation, representation-learning]
|
||||
year: 2024
|
||||
github: https://github.com/TheLuoFengLab/ChemFM
|
||||
last_checked: 2026-10-02
|
||||
metadata_sources:
|
||||
- https://github.com/TheLuoFengLab/ChemFM
|
||||
|
||||
esm_cambrian_esm_c:
|
||||
entities: [protein]
|
||||
methods: [language-model, self-supervised-learning, transformer]
|
||||
modalities: [protein-sequence]
|
||||
tasks: [foundation-model-pretraining, protein-function-prediction, representation-learning]
|
||||
year: 2024
|
||||
github: https://github.com/Biohub/esm
|
||||
last_checked: 2026-10-02
|
||||
metadata_sources:
|
||||
- https://github.com/Biohub/esm
|
||||
- https://www.evolutionaryscale.ai/blog/esm-cambrian
|
||||
|
||||
boltz_2:
|
||||
entities: [molecule, protein, protein-complex]
|
||||
methods: [diffusion, generative-model, transformer]
|
||||
modalities: [molecular-structure, protein-sequence]
|
||||
tasks: [drug-target-interaction, structure-prediction, virtual-screening]
|
||||
year: 2025
|
||||
github: https://github.com/jwohlwend/boltz
|
||||
paper: https://doi.org/10.1101/2025.06.14.659707
|
||||
last_checked: 2026-10-02
|
||||
metadata_sources:
|
||||
- https://github.com/jwohlwend/boltz
|
||||
- https://doi.org/10.1101/2025.06.14.659707
|
||||
|
||||
protenix:
|
||||
entities: [molecule, protein, protein-complex]
|
||||
methods: [diffusion, generative-model, transformer]
|
||||
modalities: [molecular-structure, protein-sequence]
|
||||
tasks: [drug-target-interaction, structure-prediction]
|
||||
year: 2025
|
||||
github: https://github.com/bytedance/Protenix
|
||||
last_checked: 2026-10-02
|
||||
metadata_sources:
|
||||
- https://github.com/bytedance/Protenix
|
||||
|
||||
rna_fm:
|
||||
entities: [gene, transcript]
|
||||
methods: [language-model, self-supervised-learning, transformer]
|
||||
modalities: [rna-sequence]
|
||||
tasks: [foundation-model-pretraining, representation-learning, structure-prediction]
|
||||
year: 2022
|
||||
github: https://github.com/ml4bio/RNA-FM
|
||||
last_checked: 2026-10-02
|
||||
metadata_sources:
|
||||
- https://github.com/ml4bio/RNA-FM
|
||||
|
||||
rinalmo:
|
||||
entities: [gene, transcript]
|
||||
methods: [language-model, self-supervised-learning, transformer]
|
||||
modalities: [rna-sequence]
|
||||
tasks: [foundation-model-pretraining, representation-learning, structure-prediction]
|
||||
year: 2024
|
||||
github: https://github.com/lbcb-sci/RiNALMo
|
||||
last_checked: 2026-10-02
|
||||
metadata_sources:
|
||||
- https://github.com/lbcb-sci/RiNALMo
|
||||
|
||||
evo_2:
|
||||
entities: [gene, genome, organism]
|
||||
methods: [generative-model, language-model]
|
||||
modalities: [dna-sequence, genomics]
|
||||
tasks: [foundation-model-pretraining, representation-learning]
|
||||
year: 2026
|
||||
github: https://github.com/arcinstitute/evo2
|
||||
paper: https://doi.org/10.1038/s41586-026-10176-5
|
||||
last_checked: 2026-10-02
|
||||
metadata_sources:
|
||||
- https://github.com/arcinstitute/evo2
|
||||
- https://doi.org/10.1038/s41586-026-10176-5
|
||||
|
||||
alphagenome:
|
||||
entities: [gene, genome, regulatory-element, variant]
|
||||
methods: [supervised-learning, transformer]
|
||||
modalities: [dna-sequence, epigenomics, genomics]
|
||||
tasks: [regression, representation-learning]
|
||||
year: 2025
|
||||
github: https://github.com/google-deepmind/alphagenome
|
||||
last_checked: 2026-10-02
|
||||
metadata_sources:
|
||||
- https://github.com/google-deepmind/alphagenome
|
||||
|
||||
moderngena:
|
||||
entities: [gene, genome, regulatory-element]
|
||||
methods: [language-model, self-supervised-learning, transformer]
|
||||
modalities: [dna-sequence, genomics]
|
||||
tasks: [classification, foundation-model-pretraining, regression, representation-learning]
|
||||
year: 2026
|
||||
github: https://github.com/AIRI-Institute/GENA_LM
|
||||
last_checked: 2026-10-02
|
||||
metadata_sources:
|
||||
- https://github.com/AIRI-Institute/GENA_LM
|
||||
+292
@@ -0,0 +1,292 @@
|
||||
---
|
||||
title: "Genetic perturbation Dataset Explorer metadata; artifact sync verified."
|
||||
task: ""
|
||||
lineage_type: import
|
||||
upstream_source: https://github.com/inoue0426/awesome-computational-biology/blob/4ed7cfef/data/enrichment.genetic-perturbation-v1.yml
|
||||
upstream_sha: 4ed7cfef
|
||||
imported_at: 2026-10-26
|
||||
prompt_class: catalogue
|
||||
upstream_changes: accepted
|
||||
author: upstream
|
||||
validated: false
|
||||
---
|
||||
|
||||
# Genetic perturbation Dataset Explorer metadata; artifact sync verified.
|
||||
# Curated genetic perturbation datasets for Dataset Explorer.
|
||||
resources:
|
||||
dixit_et_al_2016_perturb_seq:
|
||||
paper: https://doi.org/10.1016/j.cell.2016.11.038
|
||||
last_checked: 2026-10-02
|
||||
metadata_sources:
|
||||
- https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE90063
|
||||
- https://doi.org/10.1016/j.cell.2016.11.038
|
||||
dataset_profile:
|
||||
year: 2016
|
||||
view_scope: full-study
|
||||
species: [human, mouse]
|
||||
sample_type: cell-line+primary
|
||||
biological_context: immune-and-cell-line
|
||||
perturbation_type: [genetic]
|
||||
genetic_modes: [crispr-ko, combinatorial]
|
||||
readout: single-cell-rna
|
||||
n_profiles: "~200,000 cells"
|
||||
n_perturbations: "pooled CRISPR-KO across six screens"
|
||||
n_contexts: 6
|
||||
gene_panel: transcriptome-wide
|
||||
paired: true
|
||||
pre_post: false
|
||||
longitudinal: false
|
||||
drug_identity: false
|
||||
dose: false
|
||||
time: true
|
||||
smiles: false
|
||||
clinical_outcome: false
|
||||
n_samples: "six pooled screens across K562 and dendritic-cell conditions"
|
||||
n_cells: "~200,000"
|
||||
access: open
|
||||
|
||||
adamson_et_al_2016_perturb_seq:
|
||||
paper: https://doi.org/10.1016/j.cell.2016.11.048
|
||||
last_checked: 2026-10-02
|
||||
metadata_sources:
|
||||
- https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE90546
|
||||
dataset_profile:
|
||||
year: 2016
|
||||
view_scope: full-study
|
||||
species: [human]
|
||||
sample_type: cell-line
|
||||
biological_context: unfolded-protein-response
|
||||
perturbation_type: [genetic]
|
||||
genetic_modes: [crispri, combinatorial]
|
||||
readout: single-cell-rna
|
||||
n_profiles: "~86,000 cells"
|
||||
n_perturbations: "~100 UPR hits plus combinatorial CRISPRi perturbations"
|
||||
n_contexts: 3
|
||||
gene_panel: transcriptome-wide
|
||||
paired: true
|
||||
pre_post: false
|
||||
longitudinal: false
|
||||
drug_identity: false
|
||||
dose: false
|
||||
time: false
|
||||
smiles: false
|
||||
clinical_outcome: false
|
||||
n_samples: "three pooled CRISPRi Perturb-seq experiments in K562"
|
||||
n_cells: "~86,000"
|
||||
access: open
|
||||
|
||||
datlinger_et_al_2017_crop_seq:
|
||||
paper: https://doi.org/10.1038/nmeth.4177
|
||||
last_checked: 2026-10-02
|
||||
metadata_sources:
|
||||
- https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92872
|
||||
- https://doi.org/10.1038/nmeth.4177
|
||||
dataset_profile:
|
||||
year: 2017
|
||||
view_scope: full-study
|
||||
species: [human]
|
||||
sample_type: cell-line
|
||||
biological_context: t-cell-receptor-signaling
|
||||
perturbation_type: [genetic]
|
||||
genetic_modes: [crispr-ko]
|
||||
readout: single-cell-rna
|
||||
n_profiles: 5905
|
||||
n_perturbations: "TCR regulators and transcription factors"
|
||||
n_contexts: 2
|
||||
gene_panel: transcriptome-wide
|
||||
paired: true
|
||||
pre_post: false
|
||||
longitudinal: false
|
||||
drug_identity: false
|
||||
dose: false
|
||||
time: false
|
||||
smiles: false
|
||||
clinical_outcome: false
|
||||
n_samples: "stimulated and unstimulated Jurkat CROP-seq"
|
||||
n_cells: 5905
|
||||
access: open
|
||||
|
||||
norman_et_al_2019_crispra_perturb_seq:
|
||||
paper: https://doi.org/10.1126/science.aax4438
|
||||
last_checked: 2026-10-02
|
||||
metadata_sources:
|
||||
- https://figshare.com/articles/dataset/Norman_et_al_2019_Perturb-seq/27766323
|
||||
- https://doi.org/10.1126/science.aax4438
|
||||
dataset_profile:
|
||||
year: 2019
|
||||
view_scope: full-study
|
||||
species: [human]
|
||||
sample_type: cell-line
|
||||
biological_context: genetic-interactions
|
||||
perturbation_type: [genetic]
|
||||
genetic_modes: [crispra, combinatorial]
|
||||
readout: single-cell-rna
|
||||
n_profiles: "~110,000 cells"
|
||||
n_perturbations: 287
|
||||
n_contexts: 1
|
||||
gene_panel: transcriptome-wide
|
||||
paired: true
|
||||
pre_post: false
|
||||
longitudinal: false
|
||||
drug_identity: false
|
||||
dose: false
|
||||
time: false
|
||||
smiles: false
|
||||
clinical_outcome: false
|
||||
n_samples: "single-gene and pairwise CRISPRa perturbations in K562"
|
||||
n_cells: "~110,000"
|
||||
access: open
|
||||
|
||||
gasperini_et_al_2019_crispri_enhancer_screen:
|
||||
paper: https://doi.org/10.1016/j.cell.2018.11.029
|
||||
last_checked: 2026-10-02
|
||||
metadata_sources:
|
||||
- https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE120861
|
||||
dataset_profile:
|
||||
year: 2019
|
||||
view_scope: full-study
|
||||
species: [human]
|
||||
sample_type: cell-line
|
||||
biological_context: enhancer-gene-regulation
|
||||
perturbation_type: [genetic]
|
||||
genetic_modes: [crispri, enhancer-targeting]
|
||||
readout: single-cell-rna
|
||||
n_profiles: 254974
|
||||
n_perturbations: 5920
|
||||
n_contexts: 3
|
||||
gene_panel: transcriptome-wide
|
||||
paired: true
|
||||
pre_post: false
|
||||
longitudinal: false
|
||||
drug_identity: false
|
||||
dose: false
|
||||
time: false
|
||||
smiles: false
|
||||
clinical_outcome: false
|
||||
n_samples: "three CRISPRi screens in K562, including an at-scale enhancer screen"
|
||||
n_cells: 254974
|
||||
access: open
|
||||
|
||||
replogle_et_al_2022_k562_genome_wide_perturb_seq:
|
||||
paper: https://doi.org/10.1016/j.cell.2022.05.013
|
||||
last_checked: 2026-10-02
|
||||
metadata_sources:
|
||||
- https://plus.figshare.com/articles/dataset/_Mapping_information-rich_genotype-phenotype_landscapes_with_genome-scale_Perturb-seq_Replogle_et_al_2022_processed_Perturb-seq_datasets/20029387
|
||||
- https://gwps.wi.mit.edu/
|
||||
dataset_profile:
|
||||
year: 2022
|
||||
view_scope: full-study
|
||||
species: [human]
|
||||
sample_type: cell-line
|
||||
biological_context: genome-wide-functional-genomics
|
||||
perturbation_type: [genetic]
|
||||
genetic_modes: [crispri]
|
||||
readout: single-cell-rna
|
||||
n_profiles: "genome-scale; mean ~183 cells per detected perturbation"
|
||||
n_perturbations: "9,866 target genes; 11,258 detected sgRNA-pair perturbations"
|
||||
n_contexts: 1
|
||||
gene_panel: transcriptome-wide
|
||||
paired: true
|
||||
pre_post: false
|
||||
longitudinal: false
|
||||
drug_identity: false
|
||||
dose: false
|
||||
time: true
|
||||
smiles: false
|
||||
clinical_outcome: false
|
||||
n_samples: "K562 CRISPRi genome-wide screen sampled at day 8"
|
||||
n_cells: "mean ~183 cells per detected perturbation"
|
||||
access: open
|
||||
|
||||
replogle_et_al_2022_k562_essential_perturb_seq:
|
||||
paper: https://doi.org/10.1016/j.cell.2022.05.013
|
||||
last_checked: 2026-10-02
|
||||
metadata_sources:
|
||||
- https://plus.figshare.com/articles/dataset/_Mapping_information-rich_genotype-phenotype_landscapes_with_genome-scale_Perturb-seq_Replogle_et_al_2022_processed_Perturb-seq_datasets/20029387
|
||||
- https://gwps.wi.mit.edu/
|
||||
dataset_profile:
|
||||
year: 2022
|
||||
view_scope: full-study
|
||||
species: [human]
|
||||
sample_type: cell-line
|
||||
biological_context: essential-gene-screen
|
||||
perturbation_type: [genetic]
|
||||
genetic_modes: [crispri]
|
||||
readout: single-cell-rna
|
||||
n_profiles: 310385
|
||||
n_perturbations: 2057
|
||||
n_contexts: 1
|
||||
gene_panel: transcriptome-wide
|
||||
paired: true
|
||||
pre_post: false
|
||||
longitudinal: false
|
||||
drug_identity: false
|
||||
dose: false
|
||||
time: true
|
||||
smiles: false
|
||||
clinical_outcome: false
|
||||
n_samples: "K562 CRISPRi essential-gene screen sampled at day 6"
|
||||
n_cells: 310385
|
||||
access: open
|
||||
|
||||
replogle_et_al_2022_rpe1_essential_perturb_seq:
|
||||
paper: https://doi.org/10.1016/j.cell.2022.05.013
|
||||
last_checked: 2026-10-02
|
||||
metadata_sources:
|
||||
- https://plus.figshare.com/articles/dataset/_Mapping_information-rich_genotype-phenotype_landscapes_with_genome-scale_Perturb-seq_Replogle_et_al_2022_processed_Perturb-seq_datasets/20029387
|
||||
- https://gwps.wi.mit.edu/
|
||||
dataset_profile:
|
||||
year: 2022
|
||||
view_scope: full-study
|
||||
species: [human]
|
||||
sample_type: cell-line
|
||||
biological_context: essential-gene-screen
|
||||
perturbation_type: [genetic]
|
||||
genetic_modes: [crispri]
|
||||
readout: single-cell-rna
|
||||
n_profiles: 247914
|
||||
n_perturbations: 2393
|
||||
n_contexts: 1
|
||||
gene_panel: transcriptome-wide
|
||||
paired: true
|
||||
pre_post: false
|
||||
longitudinal: false
|
||||
drug_identity: false
|
||||
dose: false
|
||||
time: true
|
||||
smiles: false
|
||||
clinical_outcome: false
|
||||
n_samples: "RPE1 CRISPRi essential-gene screen sampled at day 7"
|
||||
n_cells: 247914
|
||||
access: open
|
||||
|
||||
frangieh_et_al_2021_perturb_cite_seq:
|
||||
paper: https://doi.org/10.1038/s41588-021-00779-1
|
||||
last_checked: 2026-10-02
|
||||
metadata_sources:
|
||||
- https://singlecell.broadinstitute.org/single_cell/study/SCP1064/multi-modal-pooled-perturb-cite-seq-screens-in-patient-models-define-novel-mechanisms-of-cancer-immune-evasion
|
||||
- https://doi.org/10.1038/s41588-021-00779-1
|
||||
dataset_profile:
|
||||
year: 2021
|
||||
view_scope: full-study
|
||||
species: [human]
|
||||
sample_type: patient-derived-cell-line
|
||||
biological_context: melanoma-immunotherapy
|
||||
perturbation_type: [genetic]
|
||||
genetic_modes: [crispr-ko]
|
||||
readout: cite-seq
|
||||
n_profiles: ">200,000 cells"
|
||||
n_perturbations: 248
|
||||
n_contexts: 3
|
||||
gene_panel: "transcriptome + surface proteins"
|
||||
paired: true
|
||||
pre_post: false
|
||||
longitudinal: false
|
||||
drug_identity: false
|
||||
dose: false
|
||||
time: false
|
||||
smiles: false
|
||||
clinical_outcome: false
|
||||
n_samples: "patient-derived melanoma under control, IFN-gamma, and TIL co-culture conditions"
|
||||
n_cells: ">200,000"
|
||||
access: mixed
|
||||
+285
@@ -0,0 +1,285 @@
|
||||
---
|
||||
title: "Method Explorer v1; changes to this file trigger artifact regeneration."
|
||||
task: ""
|
||||
lineage_type: import
|
||||
upstream_source: https://github.com/inoue0426/awesome-computational-biology/blob/4ed7cfef/data/enrichment.method-explorer-v1.yml
|
||||
upstream_sha: 4ed7cfef
|
||||
imported_at: 2026-10-26
|
||||
prompt_class: unknown
|
||||
upstream_changes: accepted
|
||||
author: upstream
|
||||
validated: false
|
||||
---
|
||||
|
||||
# Method Explorer v1; changes to this file trigger artifact regeneration.
|
||||
# Structured comparison metadata for Method Explorer v1.
|
||||
resources:
|
||||
bison:
|
||||
method_profile:
|
||||
task_family: drug-perturbation
|
||||
year: 2026
|
||||
input: bulk/pseudobulk transcriptomics
|
||||
drug_representation: Morgan fingerprints + chemical tokens
|
||||
context_representation: control-derived context features + embeddings
|
||||
output: transcriptomic response
|
||||
unseen_drug: yes
|
||||
unseen_context: limited
|
||||
dose: true
|
||||
time: true
|
||||
patient_transfer: false
|
||||
code: false
|
||||
|
||||
txpert:
|
||||
method_profile:
|
||||
task_family: drug-perturbation
|
||||
year: 2026
|
||||
input: transcriptomics + biological knowledge
|
||||
drug_representation: knowledge-graph-informed perturbation representation
|
||||
context_representation: cellular context representation
|
||||
output: transcriptomic response
|
||||
unseen_drug: yes
|
||||
unseen_context: yes
|
||||
dose: false
|
||||
time: false
|
||||
patient_transfer: false
|
||||
code: true
|
||||
|
||||
lpm:
|
||||
method_profile:
|
||||
task_family: drug-perturbation
|
||||
year: 2025
|
||||
input: heterogeneous perturbation experiments
|
||||
drug_representation: learned perturbation representation
|
||||
context_representation: learned context representation
|
||||
output: molecular state
|
||||
unseen_drug: yes
|
||||
unseen_context: yes
|
||||
dose: limited
|
||||
time: limited
|
||||
patient_transfer: false
|
||||
code: true
|
||||
|
||||
state:
|
||||
method_profile:
|
||||
task_family: drug-perturbation
|
||||
year: 2026
|
||||
input: sets of cellular expression profiles
|
||||
drug_representation: perturbation embedding
|
||||
context_representation: cellular state
|
||||
output: transcriptomic response
|
||||
unseen_drug: limited
|
||||
unseen_context: yes
|
||||
dose: limited
|
||||
time: limited
|
||||
patient_transfer: false
|
||||
code: true
|
||||
|
||||
chemcpa:
|
||||
method_profile:
|
||||
task_family: drug-perturbation
|
||||
year: 2022
|
||||
input: single-cell expression + covariates
|
||||
drug_representation: RDKit2D descriptors
|
||||
context_representation: cell covariates + basal state
|
||||
output: transcriptomic response
|
||||
unseen_drug: yes
|
||||
unseen_context: limited
|
||||
dose: true
|
||||
time: limited
|
||||
patient_transfer: false
|
||||
code: true
|
||||
|
||||
cmonge:
|
||||
method_profile:
|
||||
task_family: drug-perturbation
|
||||
year: 2026
|
||||
input: source/target expression distributions
|
||||
drug_representation: RDKit2D descriptors
|
||||
context_representation: matched control distribution
|
||||
output: transported expression distribution
|
||||
unseen_drug: yes
|
||||
unseen_context: yes
|
||||
dose: true
|
||||
time: limited
|
||||
patient_transfer: false
|
||||
code: true
|
||||
|
||||
prnet:
|
||||
method_profile:
|
||||
task_family: drug-perturbation
|
||||
year: 2024
|
||||
input: basal expression + perturbation
|
||||
drug_representation: FCFP4 fingerprint
|
||||
context_representation: matched basal expression
|
||||
output: transcriptomic response
|
||||
unseen_drug: yes
|
||||
unseen_context: limited
|
||||
dose: true
|
||||
time: limited
|
||||
patient_transfer: false
|
||||
code: true
|
||||
|
||||
biolord:
|
||||
method_profile:
|
||||
task_family: drug-perturbation
|
||||
year: 2024
|
||||
input: expression + known attributes
|
||||
drug_representation: chemical descriptors
|
||||
context_representation: unknown latent attributes
|
||||
output: transcriptomic response
|
||||
unseen_drug: yes
|
||||
unseen_context: yes
|
||||
dose: true
|
||||
time: true
|
||||
patient_transfer: false
|
||||
code: true
|
||||
|
||||
perturbnet:
|
||||
method_profile:
|
||||
task_family: drug-perturbation
|
||||
year: 2025
|
||||
input: single-cell expression distributions
|
||||
drug_representation: molecular representation
|
||||
context_representation: conditional latent state
|
||||
output: cell-state distribution
|
||||
unseen_drug: yes
|
||||
unseen_context: limited
|
||||
dose: limited
|
||||
time: limited
|
||||
patient_transfer: false
|
||||
code: true
|
||||
|
||||
cellflow:
|
||||
method_profile:
|
||||
task_family: drug-perturbation
|
||||
year: 2025
|
||||
input: control/treated expression distributions
|
||||
drug_representation: molecular features
|
||||
context_representation: matched control distribution
|
||||
output: transported cell-state distribution
|
||||
unseen_drug: yes
|
||||
unseen_context: yes
|
||||
dose: true
|
||||
time: true
|
||||
patient_transfer: false
|
||||
code: true
|
||||
|
||||
prophet:
|
||||
method_profile:
|
||||
task_family: drug-perturbation
|
||||
year: 2024
|
||||
input: control expression + perturbation
|
||||
drug_representation: learned chemical representation
|
||||
context_representation: control-derived context
|
||||
output: gene-expression response
|
||||
unseen_drug: yes
|
||||
unseen_context: yes
|
||||
dose: true
|
||||
time: true
|
||||
patient_transfer: false
|
||||
code: true
|
||||
|
||||
prepr_ct:
|
||||
method_profile:
|
||||
task_family: drug-perturbation
|
||||
year: 2026
|
||||
input: aggregate expression + context graph
|
||||
drug_representation: RDKit descriptors
|
||||
context_representation: context-specific gene graph
|
||||
output: transcriptomic response
|
||||
unseen_drug: yes
|
||||
unseen_context: limited
|
||||
dose: true
|
||||
time: true
|
||||
patient_transfer: false
|
||||
code: true
|
||||
|
||||
xpert:
|
||||
method_profile:
|
||||
task_family: drug-perturbation
|
||||
year: 2026
|
||||
input: transcriptomics + heterogeneous graph
|
||||
drug_representation: Uni-Mol + knowledge graph
|
||||
context_representation: basal expression + gene embeddings
|
||||
output: transcriptomic response
|
||||
unseen_drug: yes
|
||||
unseen_context: yes
|
||||
dose: true
|
||||
time: true
|
||||
patient_transfer: false
|
||||
code: true
|
||||
|
||||
paso:
|
||||
method_profile:
|
||||
task_family: drug-response-prediction
|
||||
year: 2025
|
||||
input: pathway-aware multi-omics
|
||||
drug_representation: SMILES-derived representation
|
||||
context_representation: pathway-difference representation
|
||||
output: cell-line drug response
|
||||
unseen_drug: limited
|
||||
unseen_context: limited
|
||||
dose: false
|
||||
time: false
|
||||
patient_transfer: false
|
||||
code: true
|
||||
|
||||
dtlcdr:
|
||||
method_profile:
|
||||
task_family: drug-response-prediction
|
||||
year: 2025
|
||||
input: multimodal tumor/cell-line features + targets
|
||||
drug_representation: target-aware drug representation
|
||||
context_representation: biological sample representation
|
||||
output: preclinical/clinical response
|
||||
unseen_drug: yes
|
||||
unseen_context: limited
|
||||
dose: false
|
||||
time: false
|
||||
patient_transfer: true
|
||||
code: false
|
||||
|
||||
therapi:
|
||||
method_profile:
|
||||
task_family: drug-response-prediction
|
||||
year: 2026
|
||||
input: tumor transcriptomics + cell-line knowledge
|
||||
drug_representation: perturbation/gene-level representation
|
||||
context_representation: aligned tumor/cell-line representation
|
||||
output: patient drug response
|
||||
unseen_drug: limited
|
||||
unseen_context: yes
|
||||
dose: false
|
||||
time: false
|
||||
patient_transfer: true
|
||||
code: true
|
||||
|
||||
expresso:
|
||||
method_profile:
|
||||
task_family: drug-response-prediction
|
||||
year: 2026
|
||||
input: pretreatment tumor transcriptomics
|
||||
drug_representation: drug targets + biomarkers
|
||||
context_representation: tumor transcriptomic context
|
||||
output: patient treatment response
|
||||
unseen_drug: limited
|
||||
unseen_context: yes
|
||||
dose: false
|
||||
time: false
|
||||
patient_transfer: true
|
||||
code: false
|
||||
|
||||
perturbrx:
|
||||
method_profile:
|
||||
task_family: drug-response-prediction
|
||||
year: 2026
|
||||
input: pretreatment tumor RNA-seq + perturbation pretraining
|
||||
drug_representation: drug embedding + treatment-conditioned transition
|
||||
context_representation: patient latent state
|
||||
output: patient treatment response
|
||||
unseen_drug: limited
|
||||
unseen_context: yes
|
||||
dose: true
|
||||
time: false
|
||||
patient_transfer: true
|
||||
code: false
|
||||
+321
@@ -0,0 +1,321 @@
|
||||
---
|
||||
title: "Includes Bison benchmark coverage metadata."
|
||||
task: ""
|
||||
lineage_type: import
|
||||
upstream_source: https://github.com/inoue0426/awesome-computational-biology/blob/4ed7cfef/data/enrichment.perturbation-datasets-v1.yml
|
||||
upstream_sha: 4ed7cfef
|
||||
imported_at: 2026-10-26
|
||||
prompt_class: catalogue
|
||||
upstream_changes: accepted
|
||||
author: upstream
|
||||
validated: false
|
||||
---
|
||||
|
||||
# Includes Bison benchmark coverage metadata.
|
||||
# Curated perturbation, patient, and PDX dataset profiles for Dataset Explorer.
|
||||
resources:
|
||||
tahoe_100m:
|
||||
dataset_profile:
|
||||
year: 2025
|
||||
view_scope: bison-benchmark-view
|
||||
readout: single-cell-rna
|
||||
n_profiles: 67018
|
||||
n_compounds: 376
|
||||
n_contexts: 50
|
||||
gene_panel: "20,573 full / 2,000 HVG (Bison benchmark view)"
|
||||
time: true
|
||||
species: [human]
|
||||
sample_type: cell-line
|
||||
biological_context: cancer
|
||||
perturbation_type: [chemical]
|
||||
paired: false
|
||||
pre_post: false
|
||||
longitudinal: false
|
||||
drug_identity: true
|
||||
dose: true
|
||||
smiles: partial
|
||||
clinical_outcome: false
|
||||
n_samples: ">100 million profiles; 50 cancer cell lines; ~1,100 compounds"
|
||||
n_cells: ">100 million"
|
||||
access: open
|
||||
last_checked: 2026-10-02
|
||||
metadata_sources:
|
||||
- https://huggingface.co/datasets/tahoebio/Tahoe-100M
|
||||
|
||||
sci_plex:
|
||||
dataset_profile:
|
||||
year: 2020
|
||||
view_scope: bison-benchmark-view
|
||||
readout: pseudobulk-rna
|
||||
n_profiles: 4974
|
||||
n_compounds: 186
|
||||
n_contexts: 3
|
||||
gene_panel: "20,251 full / 2,000 HVG (Bison benchmark view)"
|
||||
time: true
|
||||
species: [human, mouse]
|
||||
sample_type: cell-line
|
||||
biological_context: perturbation-screen
|
||||
perturbation_type: [chemical]
|
||||
paired: false
|
||||
pre_post: false
|
||||
longitudinal: false
|
||||
drug_identity: true
|
||||
dose: true
|
||||
smiles: partial
|
||||
clinical_outcome: false
|
||||
n_samples: "~5,000 conditions; 188 compounds across 3 human cancer cell lines"
|
||||
n_cells: 649340
|
||||
access: open
|
||||
last_checked: 2026-10-02
|
||||
metadata_sources:
|
||||
- https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE139944
|
||||
- https://pubmed.ncbi.nlm.nih.gov/31806696/
|
||||
|
||||
mix_seq:
|
||||
dataset_profile:
|
||||
year: 2020
|
||||
view_scope: full-resource
|
||||
readout: single-cell-rna
|
||||
n_compounds: 13
|
||||
n_contexts: "100+ cell lines"
|
||||
gene_panel: "transcriptome-wide"
|
||||
time: true
|
||||
species: [human]
|
||||
sample_type: cell-line
|
||||
biological_context: cancer
|
||||
perturbation_type: [chemical, genetic]
|
||||
genetic_modes: [mixed]
|
||||
paired: false
|
||||
pre_post: false
|
||||
longitudinal: true
|
||||
drug_identity: true
|
||||
dose: true
|
||||
smiles: partial
|
||||
clinical_outcome: false
|
||||
n_samples: "pools of up to 100+ cancer cell lines; 13-drug demonstration"
|
||||
n_cells: "single-cell RNA-seq"
|
||||
access: open
|
||||
last_checked: 2026-10-02
|
||||
metadata_sources:
|
||||
- https://www.nature.com/articles/s41467-020-17440-w
|
||||
|
||||
pdx_atlas:
|
||||
dataset_profile:
|
||||
year: 2026
|
||||
view_scope: current-portal
|
||||
readout: multi-omics
|
||||
n_profiles: ">50 PDXs"
|
||||
n_contexts: "30 patients"
|
||||
gene_panel: "multi-omics"
|
||||
time: false
|
||||
species: [human, mouse]
|
||||
sample_type: pdx
|
||||
biological_context: cancer
|
||||
perturbation_type: [chemical]
|
||||
paired: true
|
||||
pre_post: false
|
||||
longitudinal: false
|
||||
drug_identity: true
|
||||
dose: false
|
||||
smiles: partial
|
||||
clinical_outcome: false
|
||||
n_samples: ">50 PDXs from 30 prostate cancer patients in the current portal"
|
||||
n_cells: null
|
||||
access: open
|
||||
last_checked: 2026-10-02
|
||||
metadata_sources:
|
||||
- https://muralportal.pdxatlas.org/
|
||||
|
||||
gse191127_breast_cancer_pre_post_chemotherapy:
|
||||
dataset_profile:
|
||||
year: 2022
|
||||
view_scope: study-cohort
|
||||
readout: bulk-rna
|
||||
n_profiles: "317 pretreatment; 22 matched pre/post deeply profiled"
|
||||
n_contexts: 1
|
||||
gene_panel: "transcriptome-wide"
|
||||
time: true
|
||||
species: [human]
|
||||
sample_type: patient
|
||||
biological_context: breast-cancer
|
||||
perturbation_type: [chemical]
|
||||
paired: true
|
||||
pre_post: true
|
||||
longitudinal: true
|
||||
drug_identity: limited
|
||||
dose: false
|
||||
smiles: partial
|
||||
clinical_outcome: true
|
||||
n_samples: "317 pretreatment biopsies; 22 matched pre/post tumors with deep profiling"
|
||||
n_cells: null
|
||||
access: open
|
||||
last_checked: 2026-10-02
|
||||
metadata_sources:
|
||||
- https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE191127
|
||||
|
||||
|
||||
op3:
|
||||
dataset_profile:
|
||||
year: 2024
|
||||
view_scope: bison-benchmark-view
|
||||
readout: bulk-rna
|
||||
n_profiles: 1813
|
||||
n_compounds: 138
|
||||
n_contexts: 4
|
||||
gene_panel: "5,198 full / 2,000 HVG"
|
||||
time: true
|
||||
species: [human]
|
||||
sample_type: cell-line
|
||||
biological_context: perturbation-screen
|
||||
perturbation_type: [chemical]
|
||||
paired: false
|
||||
pre_post: false
|
||||
longitudinal: false
|
||||
drug_identity: true
|
||||
dose: true
|
||||
smiles: true
|
||||
clinical_outcome: false
|
||||
n_samples: "1,813 profiles; 138 molecules; 4 contexts"
|
||||
n_cells: null
|
||||
access: open
|
||||
last_checked: 2026-10-02
|
||||
metadata_sources:
|
||||
- https://github.com/theislab/Chem-PerturBridge
|
||||
|
||||
vcpi_0001:
|
||||
dataset_profile:
|
||||
view_scope: bison-benchmark-view
|
||||
readout: bulk-rna
|
||||
n_profiles: 27517
|
||||
n_compounds: 2272
|
||||
n_contexts: 1
|
||||
gene_panel: "20,629 full / 2,000 HVG"
|
||||
time: true
|
||||
species: [human]
|
||||
sample_type: cell-line
|
||||
biological_context: perturbation-screen
|
||||
perturbation_type: [chemical]
|
||||
paired: false
|
||||
pre_post: false
|
||||
longitudinal: false
|
||||
drug_identity: true
|
||||
dose: true
|
||||
smiles: true
|
||||
clinical_outcome: false
|
||||
n_samples: "27,517 profiles; 2,272 molecules; 1 context"
|
||||
n_cells: null
|
||||
access: open
|
||||
last_checked: 2026-10-02
|
||||
metadata_sources:
|
||||
- https://github.com/theislab/Chem-PerturBridge
|
||||
|
||||
vcpi_0002:
|
||||
dataset_profile:
|
||||
view_scope: bison-benchmark-view
|
||||
readout: bulk-rna
|
||||
n_profiles: 18139
|
||||
n_compounds: 1488
|
||||
n_contexts: 1
|
||||
gene_panel: "20,629 full / 2,000 HVG"
|
||||
time: true
|
||||
species: [human]
|
||||
sample_type: cell-line
|
||||
biological_context: perturbation-screen
|
||||
perturbation_type: [chemical]
|
||||
paired: false
|
||||
pre_post: false
|
||||
longitudinal: false
|
||||
drug_identity: true
|
||||
dose: true
|
||||
smiles: true
|
||||
clinical_outcome: false
|
||||
n_samples: "18,139 profiles; 1,488 molecules; 1 context"
|
||||
n_cells: null
|
||||
access: open
|
||||
last_checked: 2026-10-02
|
||||
metadata_sources:
|
||||
- https://github.com/theislab/Chem-PerturBridge
|
||||
|
||||
novartis_perturbation_dataset:
|
||||
dataset_profile:
|
||||
year: 2025
|
||||
view_scope: bison-benchmark-view
|
||||
readout: bulk-rna
|
||||
n_profiles: 46748
|
||||
n_compounds: 3770
|
||||
n_contexts: 1
|
||||
gene_panel: "20,038 full / 2,000 HVG"
|
||||
time: true
|
||||
species: [human]
|
||||
sample_type: cell-line
|
||||
biological_context: perturbation-screen
|
||||
perturbation_type: [chemical]
|
||||
paired: false
|
||||
pre_post: false
|
||||
longitudinal: false
|
||||
drug_identity: true
|
||||
dose: true
|
||||
smiles: true
|
||||
clinical_outcome: false
|
||||
n_samples: "46,748 profiles; 3,770 molecules; 1 context"
|
||||
n_cells: null
|
||||
access: open
|
||||
last_checked: 2026-10-02
|
||||
metadata_sources:
|
||||
- https://github.com/theislab/Chem-PerturBridge
|
||||
|
||||
lincs_l1000_phase_1:
|
||||
dataset_profile:
|
||||
year: 2017
|
||||
view_scope: bison-benchmark-view
|
||||
readout: l1000
|
||||
n_profiles: 692787
|
||||
n_compounds: 9233
|
||||
n_contexts: 70
|
||||
gene_panel: "978 landmark genes"
|
||||
time: true
|
||||
species: [human]
|
||||
sample_type: cell-line
|
||||
biological_context: perturbation-screen
|
||||
perturbation_type: [chemical]
|
||||
paired: false
|
||||
pre_post: false
|
||||
longitudinal: false
|
||||
drug_identity: true
|
||||
dose: true
|
||||
smiles: true
|
||||
clinical_outcome: false
|
||||
n_samples: "692,787 profiles; 9,233 molecules; 70 contexts; 978 landmark genes"
|
||||
n_cells: null
|
||||
access: open
|
||||
last_checked: 2026-10-02
|
||||
metadata_sources:
|
||||
- https://github.com/theislab/Chem-PerturBridge
|
||||
|
||||
lincs_l1000_phase_2:
|
||||
dataset_profile:
|
||||
year: 2017
|
||||
view_scope: bison-benchmark-view
|
||||
readout: l1000
|
||||
n_profiles: 333263
|
||||
n_compounds: 1760
|
||||
n_contexts: 30
|
||||
gene_panel: "978 landmark genes"
|
||||
time: true
|
||||
species: [human]
|
||||
sample_type: cell-line
|
||||
biological_context: perturbation-screen
|
||||
perturbation_type: [chemical]
|
||||
paired: false
|
||||
pre_post: false
|
||||
longitudinal: false
|
||||
drug_identity: true
|
||||
dose: true
|
||||
smiles: true
|
||||
clinical_outcome: false
|
||||
n_samples: "333,263 profiles; 1,760 molecules; 30 contexts; 978 landmark genes"
|
||||
n_cells: null
|
||||
access: open
|
||||
last_checked: 2026-10-02
|
||||
metadata_sources:
|
||||
- https://github.com/theislab/Chem-PerturBridge
|
||||
+85
-4
@@ -2,9 +2,9 @@
|
||||
title: "Provenance-backed drug-response and pharmacogenomics enrichment batch."
|
||||
task: ""
|
||||
lineage_type: import
|
||||
upstream_source: https://github.com/inoue0426/awesome-computational-biology/blob/7a064bf0/data/enrichment.pharmacogenomics-v1.yml
|
||||
upstream_sha: 7a064bf0
|
||||
imported_at: 2026-08-08
|
||||
upstream_source: https://github.com/inoue0426/awesome-computational-biology/blob/4ed7cfef/data/enrichment.pharmacogenomics-v1.yml
|
||||
upstream_sha: 4ed7cfef
|
||||
imported_at: 2026-10-26
|
||||
prompt_class: catalogue
|
||||
upstream_changes: accepted
|
||||
author: upstream
|
||||
@@ -20,6 +20,25 @@ resources:
|
||||
last_checked: 2026-08-08
|
||||
metadata_sources:
|
||||
- https://biodev.github.io/BeatAML2/
|
||||
dataset_profile:
|
||||
year: 2018
|
||||
readout: ex-vivo-viability
|
||||
time: false
|
||||
view_scope: full-resource
|
||||
species: [human]
|
||||
sample_type: patient
|
||||
biological_context: cancer
|
||||
perturbation_type: [chemical]
|
||||
paired: true
|
||||
pre_post: false
|
||||
longitudinal: false
|
||||
drug_identity: true
|
||||
dose: true
|
||||
smiles: partial
|
||||
clinical_outcome: true
|
||||
n_samples: "primary AML patient samples"
|
||||
n_cells: null
|
||||
access: open
|
||||
|
||||
cancer_therapeutics_response_portal_ctrp:
|
||||
entities: [cell, drug]
|
||||
@@ -27,6 +46,27 @@ resources:
|
||||
last_checked: 2026-08-08
|
||||
metadata_sources:
|
||||
- https://portals.broadinstitute.org/ctrp/
|
||||
dataset_profile:
|
||||
year: 2013
|
||||
readout: viability
|
||||
n_compounds: ">400"
|
||||
n_contexts: "~900 cell lines"
|
||||
time: false
|
||||
view_scope: full-resource
|
||||
species: [human]
|
||||
sample_type: cell-line
|
||||
biological_context: cancer
|
||||
perturbation_type: [chemical]
|
||||
paired: true
|
||||
pre_post: false
|
||||
longitudinal: false
|
||||
drug_identity: true
|
||||
dose: true
|
||||
smiles: partial
|
||||
clinical_outcome: false
|
||||
n_samples: "~900 cancer cell lines"
|
||||
n_cells: null
|
||||
access: open
|
||||
|
||||
bindingdb_curated_sets:
|
||||
entities: [molecule, protein]
|
||||
@@ -71,9 +111,30 @@ resources:
|
||||
modalities: [single-cell-rna-seq]
|
||||
tasks: [perturbation-prediction]
|
||||
github: https://github.com/sanderlab/scPerturb
|
||||
last_checked: 2026-08-08
|
||||
last_checked: 2026-10-02
|
||||
metadata_sources:
|
||||
- https://github.com/sanderlab/scPerturb
|
||||
dataset_profile:
|
||||
year: 2024
|
||||
readout: single-cell-rna
|
||||
gene_panel: "varies by source study"
|
||||
time: true
|
||||
view_scope: harmonized-collection
|
||||
species: [human, mouse]
|
||||
sample_type: cell-line
|
||||
biological_context: perturbation-collection
|
||||
perturbation_type: [chemical, genetic]
|
||||
genetic_modes: [mixed]
|
||||
paired: false
|
||||
pre_post: false
|
||||
longitudinal: false
|
||||
drug_identity: true
|
||||
dose: true
|
||||
smiles: partial
|
||||
clinical_outcome: false
|
||||
n_samples: "scPerturb integrated perturbation datasets"
|
||||
n_cells: "multi-study single-cell compendium"
|
||||
access: open
|
||||
|
||||
genomics_of_drug_sensitivity_in_cancer_gdsc:
|
||||
entities: [cell, drug, gene]
|
||||
@@ -82,6 +143,26 @@ resources:
|
||||
last_checked: 2026-08-08
|
||||
metadata_sources:
|
||||
- https://www.cancerrxgene.org/
|
||||
dataset_profile:
|
||||
year: 2012
|
||||
readout: viability
|
||||
n_contexts: "~1,000 cell lines"
|
||||
time: false
|
||||
view_scope: full-resource
|
||||
species: [human]
|
||||
sample_type: cell-line
|
||||
biological_context: cancer
|
||||
perturbation_type: [chemical]
|
||||
paired: true
|
||||
pre_post: false
|
||||
longitudinal: false
|
||||
drug_identity: true
|
||||
dose: true
|
||||
smiles: partial
|
||||
clinical_outcome: false
|
||||
n_samples: "~1,000 cancer cell lines"
|
||||
n_cells: null
|
||||
access: open
|
||||
|
||||
cellminer_cross_database_cellminercdb:
|
||||
entities: [cell, drug, gene]
|
||||
|
||||
File diff suppressed because it is too large
Load Diff
File diff suppressed because it is too large
Load Diff
@@ -2,9 +2,9 @@
|
||||
title: "Resource Data Schema (`docs/data/resources.json`)"
|
||||
task: ""
|
||||
lineage_type: import
|
||||
upstream_source: https://github.com/inoue0426/awesome-computational-biology/blob/12d87583/docs/data/SCHEMA.md
|
||||
upstream_sha: 12d87583
|
||||
imported_at: 2026-06-26
|
||||
upstream_source: https://github.com/inoue0426/awesome-computational-biology/blob/4ed7cfef/docs/data/SCHEMA.md
|
||||
upstream_sha: 4ed7cfef
|
||||
imported_at: 2026-10-26
|
||||
prompt_class: catalogue
|
||||
upstream_changes: accepted
|
||||
author: upstream
|
||||
@@ -52,6 +52,10 @@ When contributing new resources, update `README.md` first, then regenerate artif
|
||||
| `api` | boolean | Whether programmatic API access is available. Defaults to `false`. |
|
||||
| `paper` | string | DOI or URL to preprint/peer-reviewed publication. |
|
||||
| `updated` | string | Last-known update date, recommended `YYYY-MM-DD`. |
|
||||
| `dataset_profile` | object | Optional Dataset Explorer metadata for structured comparison of datasets/benchmarks. |
|
||||
| `method_profile` | object | Optional Method Explorer metadata for structured comparison of response and perturbation methods. |
|
||||
| `foundation_profile` | object | Optional Foundation Model Explorer metadata for modality, model scale, size, and availability. |
|
||||
| `agent_profile` | object | Optional Agent Explorer metadata for agent architecture, capabilities, and scientific workflow support. |
|
||||
|
||||
## Naming and consistency guidance
|
||||
|
||||
@@ -79,3 +83,101 @@ When contributing new resources, update `README.md` first, then regenerate artif
|
||||
"updated": "2026-01-15"
|
||||
}
|
||||
```
|
||||
|
||||
## Dataset Explorer profile
|
||||
|
||||
Resources that participate in the Dataset Explorer may define a `dataset_profile` object in a modular `data/enrichment.*.yml` file. This keeps README-derived identity fields separate from deeper dataset metadata.
|
||||
|
||||
Supported v1 fields:
|
||||
|
||||
| Field | Type | Meaning |
|
||||
|---|---|---|
|
||||
| `year` | integer | Representative primary publication or public release year. |
|
||||
| `species` | array of strings | Species represented in the dataset. |
|
||||
| `sample_type` | string | Primary unit, e.g. `patient` or `cell-line`. |
|
||||
| `biological_context` | string | High-level context such as `cancer` or `perturbation-screen`. |
|
||||
| `perturbation_type` | array of strings | Chemical, genetic, or other interventions. |
|
||||
| `genetic_modes` | array of strings | Genetic perturbation mechanisms, e.g. `crispri`, `crispra`, `crispr-ko`, `enhancer-targeting`, `combinatorial`, or `mixed`. |
|
||||
| `paired` | boolean | Whether molecular/sample identity can be linked to the measured response or perturbation condition. |
|
||||
| `pre_post` | boolean | Whether matched pre-treatment and post-treatment samples are available. |
|
||||
| `longitudinal` | boolean | Whether repeated measurements over time are available as a core design feature. |
|
||||
| `drug_identity` | boolean or string | Whether treatment identity is available; strings such as `limited` may encode partial availability. |
|
||||
| `dose` | boolean | Whether dose/concentration metadata are available. |
|
||||
| `smiles` | boolean or `partial`/`limited` | Whether compound structures are directly available or can only be partially mapped. |
|
||||
| `clinical_outcome` | boolean | Whether patient-level clinical outcomes are available. |
|
||||
| `n_samples` | string | Human-readable scale summary. |
|
||||
| `n_cells` | integer, string, or null | Cell count for single-cell datasets when meaningful. |
|
||||
| `n_profiles` | integer, string, or null | Number of profiles in the curated comparison view. |
|
||||
| `n_perturbations` | integer, string, or null | Number of perturbation targets/conditions, especially useful for genetic screens. |
|
||||
| `n_compounds` | integer, string, or null | Number of compounds/molecules in the curated comparison view. |
|
||||
| `n_contexts` | integer, string, or null | Number of cellular or experimental contexts. |
|
||||
| `readout` | string | Primary readout, e.g. `bulk-rna`, `pseudobulk-rna`, `single-cell-rna`, or `viability`. |
|
||||
| `gene_panel` | string | Gene/readout panel summary, e.g. `20,251 full / 2,000 HVG` or `978 landmark genes`. |
|
||||
| `time` | boolean | Whether treatment time metadata are available. |
|
||||
| `view_scope` | string | Scope of the displayed scale fields, e.g. `full-resource`, `study-cohort`, or `bison-benchmark-view`. |
|
||||
| `access` | string | Dataset-level access summary. |
|
||||
|
||||
The v1 profiles are colocated with their existing modular `data/enrichment.*.yml` owners and rendered at `docs/dataset-explorer.html`.
|
||||
|
||||
## Method Explorer profile
|
||||
|
||||
Methods shown in the Method Explorer may define a `method_profile` object in a modular enrichment fragment.
|
||||
|
||||
| Field | Type | Meaning |
|
||||
|---|---|---|
|
||||
| `task_family` | string | High-level task, currently `drug-response-prediction` or `drug-perturbation`. |
|
||||
| `year` | integer | Publication/release year used for navigation. |
|
||||
| `input` | string | Main biological/model input. |
|
||||
| `drug_representation` | string | Chemical or treatment representation. |
|
||||
| `context_representation` | string | Cellular, patient, or experimental context representation. |
|
||||
| `output` | string | Main prediction target. |
|
||||
| `unseen_drug` | boolean/string | Support for unseen-drug generalization; `limited` denotes partial or task-dependent support. |
|
||||
| `unseen_context` | boolean/string | Support for new cellular/patient contexts. |
|
||||
| `dose` | boolean/string | Whether dose is explicitly represented. |
|
||||
| `time` | boolean/string | Whether treatment time is explicitly represented. |
|
||||
| `patient_transfer` | boolean/string | Whether the method explicitly transfers to or predicts patient response. |
|
||||
| `code` | boolean/string | Whether an implementation is linked from the curated resource entry. |
|
||||
|
||||
The Method Explorer is rendered at `docs/method-explorer.html`.
|
||||
|
||||
## Foundation Model Explorer profile
|
||||
|
||||
Foundation models shown in the Foundation Model Explorer may define a `foundation_profile` object in a modular enrichment fragment.
|
||||
|
||||
| Field | Type | Meaning |
|
||||
|---|---|---|
|
||||
| `year` | integer | Publication or release year used for navigation. |
|
||||
| `modalities` | array of strings | Fine-grained modalities such as `scrna`, `bulk-rna`, `proteomics`, `mutation`, `methylation`, `atac`, `spatial`, `pathology`, `dna`, `rna`, `chemical`, or `protein`. |
|
||||
| `params` | string or null | Human-readable parameter count or family range, e.g. `100M` or `1B / 7B / 40B`. |
|
||||
| `params_millions` | number | Largest representative parameter count in millions, used only for sorting. |
|
||||
| `pretraining_scale` | string or null | Human-readable summary of the pretraining corpus size. |
|
||||
| `species` | array of strings | Species represented in pretraining or primary use. |
|
||||
| `zero_shot` | boolean/string | Whether zero-shot use is explicitly supported; `limited` denotes task-dependent support. |
|
||||
| `finetunable` | boolean/string | Whether fine-tuning or parameter-efficient adaptation is supported. |
|
||||
| `weights` | boolean/string | Whether pretrained weights are publicly available. |
|
||||
| `code` | boolean/string | Whether implementation code is publicly available. |
|
||||
| `perturbation` | boolean/string | Whether perturbation prediction or in-silico perturbation is a supported use case. |
|
||||
| `spatial` | boolean/string | Whether spatial data are directly modeled or supported. |
|
||||
|
||||
Unknown or unverified values should be omitted rather than inferred. The Foundation Model Explorer is rendered at `docs/foundation-explorer.html`.
|
||||
|
||||
## Agent Explorer profile
|
||||
|
||||
Agentic AI systems shown in the Agent Explorer may define an `agent_profile` object in a modular enrichment fragment.
|
||||
|
||||
| Field | Type | Meaning |
|
||||
|---|---|---|
|
||||
| `year` | integer | Initial public release or publication year. |
|
||||
| `domains` | array of strings | Main scientific domains such as `general-biomedicine`, `therapeutics`, `bioinformatics`, `single-cell`, `scientific-workflow`, or `paper-to-agent`. |
|
||||
| `architecture` | string | `single-agent`, `multi-agent`, or `agent-ecosystem`. |
|
||||
| `tool_use` | boolean/string | Whether external scientific tools/APIs are used. |
|
||||
| `code_execution` | boolean/string | Whether the system executes code as part of its workflow. |
|
||||
| `web_retrieval` | boolean/string | Whether web or online database retrieval is supported. |
|
||||
| `literature` | boolean/string | Whether literature search/reasoning is explicitly supported. |
|
||||
| `omics` | boolean/string | Whether omics analysis is a first-class supported workflow. |
|
||||
| `wet_lab` | boolean/string | Whether wet-lab planning, experimental design, or laboratory-facing workflows are supported. |
|
||||
| `autonomous_experiment` | boolean/string | Whether the system can carry out iterative computational/experimental research loops. |
|
||||
| `human_in_loop` | boolean/string | Whether human collaboration or approval is an explicit part of the design. |
|
||||
| `open_source` | boolean/string | Whether implementation code is publicly available. |
|
||||
|
||||
Capability fields may use `limited` or `unknown` when support is workflow-dependent or not clearly documented. The Agent Explorer is rendered at `docs/agent-explorer.html`.
|
||||
|
||||
+4355
-79
File diff suppressed because it is too large
Load Diff
Reference in New Issue
Block a user